<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31080456</article-id>
<article-id pub-id-type="pmc">6497742</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.00364</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Watson</surname>
<given-names>Callum N.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/670309/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belli</surname>
<given-names>Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/289383/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Di Pietro</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/486053/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Neuroscience and Ophthalmology Research Group, Institute of Inflammation and Ageing, University of Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff2"><sup>2</sup><institution>National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><sup>3</sup><institution>Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana–Champaign</institution>, <addr-line>Urbana, IL</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Yun Zheng, Kunming University of Science and Technology, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mauricio Fernando Budini, Universidad de Chile, Chile; Chao Peng, University of Pennsylvania, United States</p>
</fn>
<corresp id="c001">*Correspondence: Callum N. Watson, <email>cnw763@bham.ac.uk</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to RNA, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>364</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Watson, Belli and Di Pietro.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Watson, Belli and Di Pietro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Neurodegenerative diseases (NDs) are becoming increasingly prevalent in the world, with an aging population. In the last few decades, due to the devastating nature of these diseases, the research of biomarkers has become crucial to enable adequate treatments and to monitor the progress of disease. Currently, gene mutations, CSF and blood protein markers together with the neuroimaging techniques are the most used diagnostic approaches. However, despite the efforts in the research, conflicting data still exist, highlighting the need to explore new classes of biomarkers, particularly at early stages. Small non-coding RNAs (MicroRNA, Small nuclear RNA, Small nucleolar RNA, tRNA derived small RNA and Piwi-interacting RNA) can be considered a “relatively” new class of molecule that have already proved to be differentially regulated in many NDs, hence they represent a new potential class of biomarkers to be explored. In addition, understanding their involvement in disease development could depict the underlying pathogenesis of particular NDs, so novel treatment methods that act earlier in disease progression can be developed. This review aims to describe the involvement of small non-coding RNAs as biomarkers of NDs and their potential role in future clinical applications.</p>
</abstract>
<kwd-group>
<kwd>small non-coding RNAs</kwd>
<kwd>microRNAs</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>biomarkers</kwd>
<kwd>new therapeutic targets</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institute for Health Research<named-content content-type="fundref-id">10.13039/501100000227</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="175"></ref-count>
<page-count count="14"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Neurodegenerative diseases (NDs) are classified as a class of disorders affecting the central nervous system and they are characterized by the progressive loss of neuronal tissues. NDs are age-dependent disorders which are increasing internationally, due to the ever increasing elderly population, which is leaving greater numbers of people subjected to the chronic, debilitating nature of these incurable diseases (<xref ref-type="bibr" rid="B66">Heemels, 2016</xref>). Currently, the most represented NDs are: Alzheimer’disease (AD) with 5 million people affected in America only, followed by Parkinson’s diseases (PD) with 1 million people; multiple sclerosis (MS) 400,000; Amyotrophoic lateral sclerosis (ALS) 30,000 and Huntington’s disease (HD) with 3,000 incidents (<xref ref-type="bibr" rid="B3">Agrawal and Biswas, 2015</xref>).</p>
<p>Some treatments for ND have aimed to reduce the syndrome of NDs; these include L-dopa and deep brain stimulation in PD (<xref ref-type="bibr" rid="B57">Groiss et al., 2009</xref>; <xref ref-type="bibr" rid="B111">Nagatsua and Sawadab, 2009</xref>). However, very few have aimed to slow or reverse ND development, and those that have been investigated e.g., stem cell therapy (<xref ref-type="bibr" rid="B26">Chung et al., 2002</xref>; <xref ref-type="bibr" rid="B116">Rachakonda et al., 2004</xref>) highlight the requirement for more research. Late diagnosis leads to strategic treatment being ineffective due to irreversible disease progression (<xref ref-type="bibr" rid="B132">Sheinerman and Umansky, 2013</xref>). This has been reported for example, on anti-AD therapies in late-stage clinical trials (including dimebon of Medivation and Pfizer, solanezumab of Eli Lilly and bapineuzumab of Pfizer and Johnson &amp; Johnson). Biomarkers for early diagnosis could prevent or limit disease development through prophylactic or early treatment, which has ignited interest. Currently, the most accurate diagnosis relies on neuropathology, mainly based on autopsy, or in the measurement of cerebrospinal fluid (CSF) proteins, such as tau or Aβ- in AD, which requires invasive procedures. However, blood proteins, such as Aβ1-42 peptide in AD or cytokines for ALS or HD (<xref ref-type="bibr" rid="B3">Agrawal and Biswas, 2015</xref>), as well as genetics diagnostics markers such as ApoE isoforms in AD or α-synuclein or Parkin for PD, have also demonstrated potential clinical utility (<xref ref-type="bibr" rid="B3">Agrawal and Biswas, 2015</xref>).</p>
<p>Neuroimaging techniques can also help to make the correct diagnosis and monitor the progress of NDs. Magnetic resonance imaging (MRI) is one of the most widely used neuroimaging techniques used for AD (<xref ref-type="bibr" rid="B71">Jack et al., 2011</xref>; <xref ref-type="bibr" rid="B107">McKhann et al., 2011</xref>) and for dementia with Lewy bodies (DLB) (<xref ref-type="bibr" rid="B27">Ciurleo et al., 2014</xref>). Magnetic resonance spectroscopy (MRS) has also showed promise in early diagnosis of PD and traumatic brain injury, measuring metabolic dysfunctions and irreversible neuronal damage (<xref ref-type="bibr" rid="B150">Vagnozzi et al., 2008</xref>).</p>
<p>Recently, a new class of circulating RNAs – non-coding RNAs – have been re-evaluated and are being considered as potential biomarkers. After years of the belief that 98% of the genome was “junk” due to its non-coding nature it was realized these genes had biologically functionality. Non-coding genes include introns, pseudogenes, repeat sequences and <italic>cis</italic>/<italic>trans-</italic>regulatory elements that function as RNA without translation. Estimations have suggested that 99% of total RNA content is made up of non-coding RNA, with numbers of validated non-coding RNAs (ncRNAs) increasing every year (<xref ref-type="bibr" rid="B115">Palazzo and Lee, 2015</xref>).</p>
<p>Currently ncRNAs can be defined by length – small 18–200 nts and long &gt;200nts – or functionality with housekeeping ncRNAs such as ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs) or regulatory ncRNAs like microRNAs (miRNAs), small nuclear RNAs (snRNAs), piwi-interacting RNA (piRNAs), tRNA derived small RNAs (tsRNAs) and long non-coding RNAs (lncRNAs) (<xref ref-type="bibr" rid="B39">Dozmorov et al., 2013</xref>). Nonetheless, difficulty distinguishing categories persists due to the crossover of properties.</p>
<p>Small non-coding RNAs (sncRNAs) have diverse roles, which in conjunction with other molecules involve gene regulation through either RNA interference, RNA modification or spliceosomal involvement (<xref ref-type="table" rid="T1">Table 1</xref>). Consequently, during disease progression their expression can alter. MiRNAs are the most studied sncRNA as biomarkers with involvement in various diseases including cancers, aging and neurodegenerative disease (<xref ref-type="bibr" rid="B18">Calin and Croce, 2006</xref>; <xref ref-type="bibr" rid="B55">Grasso et al., 2014</xref>; <xref ref-type="bibr" rid="B34">Di Pietro et al., 2017</xref>). Other sncRNAs have shown promise as biomarkers, with links to neurodegenerative disease (<xref ref-type="bibr" rid="B109">Munoz-Culla et al., 2016</xref>). There is the potential for multiple sncRNA biomarkers for neurodegenerative diseases, which if found, could aid diagnosis in a clinical setting while demonstrating the processes underpinning the disease development. In future, this could produce novel therapies to treat neurodegenerative diseases using original methodologies.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Classification of types of small non-coding RNAs.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Type of small non-coding RNA</th>
<th align="center" colspan="1" rowspan="1" valign="top">Size (nts)</th>
<th align="center" colspan="1" rowspan="1" valign="top">Function</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MicroRNA (miRNA)</td>
<td align="center" colspan="1" rowspan="1" valign="top">∼22</td>
<td align="center" colspan="1" rowspan="1" valign="top">Ago – RNAi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Small nuclear RNA (snRNA)</td>
<td align="center" colspan="1" rowspan="1" valign="top">∼150</td>
<td align="center" colspan="1" rowspan="1" valign="top">Spliceosome components</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Small nucleolar RNA (snoRNA)</td>
<td align="center" colspan="1" rowspan="1" valign="top">60–140</td>
<td align="center" colspan="1" rowspan="1" valign="top">RNA modification</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Piwi-interacting RNA (piRNA)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26–31</td>
<td align="center" colspan="1" rowspan="1" valign="top">PIWI – RNAi</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">tRNA derived small RNA (tsRNA)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15–50</td>
<td align="center" colspan="1" rowspan="1" valign="top">Diverse</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In this review, we consider the evolving role of sncRNAs and discuss their involvement in neurodegenerative disease with particular emphasis on their potential as biomarkers.</p>
</sec>
<sec>
<title>MicroRNA</title>
<p>MiRNAs are the most studied sncRNA. Their biogenesis commences with the formation of a pri-miRNA made up of two stem-loop structure. A Drosha and DGCR8 complex cleaves the pri-miRNA to form a single stem-loop pre-miRNA. Dicer cleaves the pre-miRNA to create a double stranded miRNA, which is loaded onto Argonaute family of proteins to form the miRISC complex (<xref ref-type="fig" rid="F1">Figure 1Ai</xref>). Accompanied to the miRISC complex, miRNAs regulate gene expression post-transcriptionally through degradation and repression of mRNA sequences by an Argonaute family protein mediated method (<xref ref-type="fig" rid="F1">Figure 1Aii</xref>; <xref ref-type="bibr" rid="B112">O’Brien et al., 2018</xref>). A single miRNA can have multiple targets, likewise a target mRNA can be bound to by many different miRNAs, to enable more diverse signaling patterns.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Biogenesis of sncRNAs and an example of their biological function. <bold>A (i)</bold> MicroRNAs are single stranded ∼22 bp sequences formed from double stranded precursors <bold>(ii)</bold> that prevent mRNA translation. <bold>B (i)</bold> Small nuclear RNAs biogenesis is made up of two classes Sm class snRNA and Lsm-class snRNA (Not shown), <bold>(ii)</bold> which form the major and minor spliceosome. <bold>C (i)</bold> Small nucleolar RNAs have two different classes formed using different machinery; Box C/D RNA and Box H/ACA RNA, <bold>(ii)</bold> which cause methylation and pseudouridylation respectively. <bold>D (i)</bold> Piwi interacting RNAs are formed by either primary alone or by both primary and secondary biogenesis <bold>(ii)</bold> that prevent transposon translation through methylation. <bold>E (i)</bold> Transfer RNA cleavage forms transfer RNA derived fragments to be formed, <bold>(ii)</bold> which can prevent translation or cause gene repression.</p>
</caption>
<graphic xlink:href="fgene-10-00364-g001"></graphic>
</fig>
<p>MiRNAs show specific signaling in the brain, and were also found differentially expressed in bio-fluids. Although there is no consistent consensus on particular miRNAs or brain area yet, and no specific miRNA overlap between brain tissues and bio-fluids (as reported in <xref ref-type="table" rid="T2">Table 2</xref>) these findings certainly provide insights in the study of NDs pathogenesis.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>MiRNAs with an involvement in the neurodegenerative disease development.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Neurodegenerative disease</th>
<th align="center" colspan="1" rowspan="1" valign="top">Source</th>
<th align="center" colspan="1" rowspan="1" valign="top">miRNA</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-106b-5p, miR-106a-5p, miR-107, miR-9-5p (<xref ref-type="bibr" rid="B167">Yilmaz et al., 2016a</xref>)<break></break>Let-7d-5p, Let-7f-5p, miR-107, miR-26a-5p, miR-26b-5p (<xref ref-type="bibr" rid="B89">Leidinger et al., 2013</xref>)<break></break>miR-142-5p (<xref ref-type="bibr" rid="B134">Sorensen et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain tissues</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-9, miR-128 (<xref ref-type="bibr" rid="B96">Lukiw, 2007</xref>)<break></break>miR-26a, miR-27b, miR-30e-5p, miR-34a, miR-92, miR-125, miR-145, miR-200c, miR-381, miR-422a, miR-423 miR-9, miR-132, miR-146b, miR-212 (<xref ref-type="bibr" rid="B28">Cogswell et al., 2008</xref>)<break></break>miR-197, miR-511, miR-320, let-7i, miR-101, miR-106b, miR-15a, miR-181c, miR-19b, miR-22, miR-210, miR-26b, miR-29b-1, miR-363, miR-9, miR-93 (<xref ref-type="bibr" rid="B65">Hebert et al., 2008</xref>)<break></break>miR-29a (<xref ref-type="bibr" rid="B133">Shioya et al., 2010</xref>)<break></break>miR-26b (<xref ref-type="bibr" rid="B2">Absalon et al., 2013</xref>)<break></break>miR-370, miR-328, miR-138, miR-132 and miR-15a (<xref ref-type="bibr" rid="B9">Bekris et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CSF</td>
<td align="left" colspan="1" rowspan="1" valign="top">let-7f, miR-105, miR-125a, miR-135a, miR-138, miR-141, miR-151, miR-186, miR-191, miR-197, miR-204, miR-205, miR-216, miR-302b, miR-30a5p, miR-30a3p, miR-30b, miR-30c, miR-30d, miR-32, miR-345, miR-362, miR-371, miR-374, miR-375, miR-380-3p, miR-429, miR-448, miR-449, miR-494, miR-501, miR-517, miR-517b, miR-518b, miR-518f, miR-520a<sup>∗</sup>, miR-526a, miR-10a, miR-10b, miR-125, miR-126<sup>∗</sup>, miR-127, miR-142-5p, miR-143, miR-146b, miR-154, miR-15b, miR-181a, miR-181c, miR-194, miR-195, miR-199a<sup>∗</sup>, miR-214, miR-221, miR-328b, miR-422, miR-451, miR-455, miR-497, miR-99a (<xref ref-type="bibr" rid="B9">Bekris et al., 2013</xref>)<break></break>miR-9, miR-125b, miR-146a, miR-155 (<xref ref-type="bibr" rid="B4">Alexandrov et al., 2012</xref>)<break></break>let-7b (<xref ref-type="bibr" rid="B88">Lehmann et al., 2012</xref>)<break></break>miR-146a, miR-155 (<xref ref-type="bibr" rid="B97">Lukiw et al., 2012</xref>)<break></break>miR27a-3p (<xref ref-type="bibr" rid="B124">Sala Frigerio et al., 2013</xref>)<break></break>miR-100, miR-146a, miR-296, miR-3622b-3p, miR-4467, miR-505, miR-766, miR-103, miR1274a, miR-375, miR-708, miR-219 (<xref ref-type="bibr" rid="B33">Denk et al., 2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-142-3p, miR-483-5p (<xref ref-type="bibr" rid="B110">Nagaraj et al., 2017</xref>)<break></break>miR-125b-5p, miR-29b-3p, miR-3065-5p, miR-342-3p/5p (<xref ref-type="bibr" rid="B95">Lugli et al., 2015</xref>)<break></break>miR-107 (<xref ref-type="bibr" rid="B161">Wang et al., 2008</xref>)<break></break>miR-34a (<xref ref-type="bibr" rid="B11">Bhatnagar et al., 2014</xref>)<break></break>miR-146a, miR-34a (<xref ref-type="bibr" rid="B79">Kiko et al., 2014</xref>)<break></break>Let-7d-5p, Let-7g-5p, miR-142-3p, miR-15b-5p, miR-191-5p (<xref ref-type="bibr" rid="B82">Kumar et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Serum</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-143, miR-146a, miR-93 (<xref ref-type="bibr" rid="B37">Dong et al., 2015</xref>)<break></break>miR-125b, miR-26b (<xref ref-type="bibr" rid="B50">Galimberti et al., 2014</xref>)<break></break>Let-7d-5p, Let-7g-5p, miR-191-5p, miR-26b-3p, miR-30e-5p, miR-342-3p, miR-483-3p (<xref ref-type="bibr" rid="B142">Tan et al., 2014b</xref>)<break></break>miR-125b, miR-181c, miR-9 (<xref ref-type="bibr" rid="B141">Tan et al., 2014a</xref>)<break></break>miR-106b-3p, miR-181c-3p, miR-26a-5p (<xref ref-type="bibr" rid="B60">Guo R. et al., 2017</xref>)<break></break>Let-7f-5p, miR-26b-5p, miR-501-3p (<xref ref-type="bibr" rid="B64">Hara et al., 2017</xref>)<break></break>miR-125b (<xref ref-type="bibr" rid="B72">Jia and Liu, 2016</xref>)<break></break>miR-106a-5p, miR-106b-3p, miR-143-3p, miR-15b-3p, miR-3065-5p, miR-30e-5p, miR-342-3p, miR-93-5p (<xref ref-type="bibr" rid="B23">Cheng et al., 2015</xref>)<break></break>miR-181c (<xref ref-type="bibr" rid="B53">Geekiyanage et al., 2012</xref>)<break></break>miR-455-3p (<xref ref-type="bibr" rid="B84">Kumar et al., 2017</xref>)<break></break>miR-222 (<xref ref-type="bibr" rid="B170">Zeng et al., 2017</xref>)<break></break>miR-29c-3p, miR-19b-3p (<xref ref-type="bibr" rid="B163">Wu et al., 2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PBMCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-29b (<xref ref-type="bibr" rid="B155">Villa et al., 2013</xref>)<break></break>Let-7f, miR-34a (<xref ref-type="bibr" rid="B126">Schipper et al., 2007</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Early onset Parkinsons disease (EOPD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-1, miR-22, miR-29a (<xref ref-type="bibr" rid="B101">Margis et al., 2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain tissues</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-34b,c (<xref ref-type="bibr" rid="B108">Minones-Moyano et al., 2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-331-5p (<xref ref-type="bibr" rid="B19">Cardo et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Serum</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-141, miR-146b-5p, miR-193a-3p, miR-214 (<xref ref-type="bibr" rid="B38">Dong et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Late onset Parkinson’s disease (LOPD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole Blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-103a, miR29a, miR-30b (<xref ref-type="bibr" rid="B129">Serafin et al., 2015</xref>)<break></break>miR-3143, miR-335-3p, miR-4671-3p, miR-561-3p, miR-579-3p (<xref ref-type="bibr" rid="B168">Yilmaz et al., 2016b</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain tissues</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-34b,c (<xref ref-type="bibr" rid="B108">Minones-Moyano et al., 2011</xref>)<break></break>miR-181a,b,c,d, miR-22, miR-29a,b,c (<xref ref-type="bibr" rid="B92">Liao et al., 2013</xref>)<break></break>miR-106a, miR-21, miR-224, miR-26b, miR-301b, miR-373 (<xref ref-type="bibr" rid="B5">Alvarez-Erviti et al., 2013</xref>)<break></break>miR-205 (<xref ref-type="bibr" rid="B25">Cho et al., 2013</xref>)<break></break>miR-135b, miR-198, miR-485-5p, miR-548d (<xref ref-type="bibr" rid="B20">Cardo et al., 2014</xref>)<break></break>Let-7i-3p/5p, miR-10b-5p, miR-1224, miR-127-3p, miR-127-5p, miR-16-5p, miR-184, miR-29a-3p (<xref ref-type="bibr" rid="B67">Hoss et al., 2016</xref>)<break></break>miR-144, miR-145, miR-199b, miR-221, miR-488, miR-543, miR-544, miR-7 (<xref ref-type="bibr" rid="B144">Tatura et al., 2016</xref>)<break></break>miR-225, miR-236, miR-46 (<xref ref-type="bibr" rid="B158">Wake et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CSF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Let-7g-3p, miR-1224-5p, miR-127-3p, miR-128, miR-132-5p, miR-19a,b, miR-212-3p, miR-370, miR-409-3p, miR-4448, miR-485-5p, miR-873-3p (<xref ref-type="bibr" rid="B15">Burgos et al., 2014</xref>)<break></break>Let-7g-3p, miR-1, miR-103a, miR-10a-5p, miR-119a, miR-126, miR-127-3p, miR-132-5p, miR-136-3p, miR-151, miR-153, miR-16-2, miR-19b-3p, miR-22, miR-26a, miR-28, miR-29a,c, miR-301a, miR-30b, miR-331-5p, miR-370, miR-374, miR-409-3p, miR-433, miR-485-5p, miR-873-3p (<xref ref-type="bibr" rid="B59">Gui et al., 2015</xref>)<break></break>miR-1249, miR-1274b, miR-150, miR-16, miR-18b, miR-199b, miR-20a, miR-21, miR-320a,b, miR-378c, miR-4293, miR-671, miR-769, miR-92b (<xref ref-type="bibr" rid="B135">Soreq et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-222, miR-505, miR-626 (<xref ref-type="bibr" rid="B77">Khoo et al., 2012</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Serum</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-19b, miR-29a,c (<xref ref-type="bibr" rid="B14">Botta-Orfila et al., 2014</xref>)<break></break>miR-133b (<xref ref-type="bibr" rid="B175">Zhao et al., 2014</xref>)<break></break>miR-29a,b,c (<xref ref-type="bibr" rid="B8">Bai et al., 2017</xref>)<break></break>miR-146a, miR-214, miR-221, miR-29c (<xref ref-type="bibr" rid="B98">Ma et al., 2016</xref>)<break></break>miR-1294, miR-16-2-3p, miR-30a,e, miR-338-3p (<xref ref-type="bibr" rid="B15">Burgos et al., 2014</xref>)<break></break>miR-148b, miR-223, miR-24, miR-30c, miR-324-3p (<xref ref-type="bibr" rid="B151">Vallelunga et al., 2014</xref>)<break></break>miR-15b, miR-181a, miR-185, miR-195, miR-221 (<xref ref-type="bibr" rid="B36">Ding et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PBMCs</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-126, miR-126<sup>∗</sup>, miR-147, miR-151-3p,5p, miR-199a-3p,5p, miR-199b, miR-19b, miR-26a, miR-28-5p, miR-29b,c, miR-301a, miR-30b,c, miR-335, miR-374a,b (<xref ref-type="bibr" rid="B103">Martins et al., 2011</xref>)<break></break>miR-155, miRNA-146a (<xref ref-type="bibr" rid="B17">Caggiu et al., 2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Amyotrophic lateral sclerosis (ALS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole Blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">let-7a-5p, let-7d-5p, let-7f-5p, let-7g-5p, let-7i-5p, miR-103a-3p, miR-106b-3p, miR-128-3p, miR-130a-3p, miR-130b-3p, miR-144-5p, miR-148a-3p, miR-148b-3p, miR-15a-5p, miR-15b-5p, miR-151a-5p, miR-151b, miR-16-5p, miR-182-5p, miR-183-5p, miR-186-5p, miR-22-3p, miR-221-3p, miR-223-3p, miR-23a-3p, miR-26a-5p, miR-26b-5p, miR-27b-3p, miR-28-3p, miR-30b-5p, miR-30c-5p, miR-342-3p, miR-425-5p, miR-451a, miR-532-5p, miR-550a-3p, miR-584-5p, miR-93-5p (<xref ref-type="bibr" rid="B93">Liguori et al., 2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CSF</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-150, miR-99b, miR-146a, miR-27b, miR-328, miR-532-3p (<xref ref-type="bibr" rid="B16">Butovsky et al., 2012</xref>)<break></break>miR-132-5p, miR-132-3p, miR-143-3p, miR-143-5p, miR-574-5p (<xref ref-type="bibr" rid="B45">Freischmidt et al., 2013</xref>)<break></break>miR-338-3p (<xref ref-type="bibr" rid="B31">De Felice et al., 2014</xref>)<break></break>miR-181a-5p, miR-21-5p, miR-195-5p, miR-148-3p, miR-15b-5p, miR-let7a-5p, miR-let7b-5p, miR-let7f-5p (<xref ref-type="bibr" rid="B10">Benigni et al., 2016</xref>)<break></break>miR-124-3p, miR-127-3p, miR-143-3p, miR-125b-2-3p, miR-9-5p, miR-27b-3p, miR-486-5p, miR-let7f-5p, miR-16-5p, miR-28-3p, miR-146a-3p, miR-150-5p, miR-378a-3p, miR-142-5p, miR-92a-5p (<xref ref-type="bibr" rid="B160">Waller et al., 2017b</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-4649-5p, miR-4299 (<xref ref-type="bibr" rid="B140">Takahashi et al., 2015</xref>)<break></break>miR-424, miR-206 (<xref ref-type="bibr" rid="B30">de Andrade et al., 2016</xref>)<break></break>miR-206, Pairs miR-206/miR-338-3p, miR-9<sup>∗</sup>/miR-129-3p, miR-335-5p/miR-338-3p (<xref ref-type="bibr" rid="B131">Sheinerman et al., 2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Serum</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-132-3p, miR-132-5p, miR-143-3p, miR-143-5p, let-7b (<xref ref-type="bibr" rid="B45">Freischmidt et al., 2013</xref>)<break></break>miR-206, miR-106b (<xref ref-type="bibr" rid="B145">Toivonen et al., 2014</xref>)<break></break>miR-4745-5p, miR-3665, miR-4530, miR-1915-3p (<xref ref-type="bibr" rid="B47">Freischmidt et al., 2014</xref>)<break></break>miR-1825, miR-1234-3p (<xref ref-type="bibr" rid="B46">Freischmidt et al., 2015</xref>)<break></break>miR-206, miR-133a, miR-133b, miR-146a, miR-149<sup>∗</sup>, miR-27a (<xref ref-type="bibr" rid="B143">Tasca et al., 2016</xref>)<break></break>miR-1, miR-133a-3p, miR-133b, miR-144-5p, miR-192-3p, miR-195-5p, miR-19a-3p, let-7d-3p, miR-320a, miR-320b, miR-320c, miR-425-5p, miR-139-5p (<xref ref-type="bibr" rid="B117">Raheja et al., 2018</xref>)<break></break>miR-206, miR-143-3p, miR-374b-5p (<xref ref-type="bibr" rid="B159">Waller et al., 2017a</xref>)<break></break>miR-142-3p, miR-1249-3p (<xref ref-type="bibr" rid="B105">Matamala et al., 2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Huntington’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brain tissues</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-9/miR-9<sup>∗</sup>, miR-124a, miR-132 (<xref ref-type="bibr" rid="B114">Packer et al., 2008</xref>)<break></break>miR-10b-5p, miR-196a-5p, miR-615-3p, miR-10b-3p, miR-1298-3p, miR-196b-5p, miR-302a-3p, miR-1247-5p, miR-144-3p, miR-223-3p, miR-3200-3p, miR-302a-5p, miR-1264, miR-6734-5p, miR-144-5p, miR-138-2-5p, miR-431-5p, miR-132-3p, miR-200c-3p, miR-23b-5p, miR-448, miR-486-3p, miR-490-5p, miR-5695, miR-885-5p, miR-1224-5p, miR-1298-5p, miR-142-3p, miR-346, miR-891a-5p, miR-16-2-3p, miR-363-3p, miR-148a-3p, miR-199a-5p, miR-4449, miR-106a-5p, miR-142-5p, miR-549a, miR-214-5p, miR-141-3p, miR-5680, miR-3065-5p, miR-224-5p, miR-4787-3p, miR-452-5p, miR-129-1-3p, miR-4443, miR-101-5p, miR-483-5p, miR-2114-5p, miR-1185-1-3p, miR-670-3p, miR-129-5p, miR-135b-5p, miR-194-5p, miR-208b-3p, miR-4488, miR-888-5p, miR-126-5p, miR-34c-5p, miR-218-1-3p, miR-150-5p, miR-486-5p, miR-433-3p, miR-219b-3p, miR-548n, miR-663b, miR-148a-5p, miR-29a-3p, miR-320b, miR-181a-3p, miR-153-5p, miR-28-5p, miR-7-2-3p, miR-877-5p, miR-3687, miR-4516, miR-3139, miR-663a, miR-34b-3p, miR-1538 (<xref ref-type="bibr" rid="B68">Hoss et al., 2015a</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CSF</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-520f-3p, miR-135b-3p, miR-4317, miR-3928-5p, miR-8082, miR-140-5p (<xref ref-type="bibr" rid="B120">Reed et al., 2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-10b-5p, miR-486-5p (<xref ref-type="bibr" rid="B69">Hoss et al., 2015b</xref>)<break></break>miR-34b (<xref ref-type="bibr" rid="B51">Gaughwin et al., 2011</xref>)<break></break>miR-877-5p, miR-223-3p/5p, miR-30d-5p, miR-128, miR-22-5p, miR-222-3p, miR-338-3p, miR-130b-3p, miR-425-5p, miR-628-3p, miR-361-5p, miR-942 (<xref ref-type="bibr" rid="B35">Diez-Planelles et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup>∗</sup>Passenger miRNA strand.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>MiRNAs are best studied in Alzheimer’s disease (AD), which manifests itself as deposition of neurofibrillary tangles (NFT) and extracellular amyloid-β (Aβ), before neuronal degeneration and clinical symptoms materialize in the form of behavioral changes such as memory issues. NFT, Aβ and neuronal degeneration have been associated with dysregulation of miRNA gene expression, which could emanate from altered Aβ or Tau metabolism. MiRNAs effect Aβ metabolism by interacting with amyloid precursor protein (APP) through direct binding of the 3′untranslated region (3′UTR) to the APP mRNA, indirect inhibition through downregulation of Beta-secretase 1 (BACE1) and ATP-binding cassette transporter (ABCA1) or regulating alternative APP splicing. MiRNAs also affect Tau through regulation of microtubule associated protein tau (MAPT) splicing, affecting tau isoforms 3R and 4R. Direct or indirect binding either modulates phosphorylated Tau-associated protein kinases or influences degradation of phosphorylated tau by binding 3′-UTR BCL2 associated athanogene 2 (BAG2) mRNA (<xref ref-type="bibr" rid="B174">Zhao et al., 2017</xref>).</p>
<p>MiRNAs have an established involvement in neurobiological functions and pathogenesis of numerous other neurodegenerative diseases (<xref ref-type="bibr" rid="B128">Serafin et al., 2014</xref>; <xref ref-type="bibr" rid="B43">Fransquet and Ryan, 2018</xref>; <xref ref-type="bibr" rid="B121">Ricci et al., 2018</xref>). Mitochondrial dysfunction caused by miRNA dysregulation leads to oxidative stress, which causes cell death, α-synuclein aggregation and neurodegeneration known to be present in PD (<xref ref-type="bibr" rid="B136">Spano et al., 2015</xref>). In ALS, both TAR DNA binding protein (TARDBP) and fused in sarcoma (FUS) are well-established causative genes, which are involved in miRNA processing. TARDBP has specific roles in facilitation of post-transcriptional processing achieved through association directly with miRNA or processing factors such as Dicer (<xref ref-type="bibr" rid="B76">Kawahara and Mieda-Sato, 2012</xref>). FUS regulates miRNA-mediated gene silencing through facilitation of the interaction between miRNA, mRNA and RISC components (<xref ref-type="bibr" rid="B171">Zhang et al., 2018</xref>). In HD, a miRNA formulation is being trailed as therapeutic agents to alter the aberrant Huntingtin (HTT) protein expression (<xref ref-type="bibr" rid="B6">Aronin and DiFiglia, 2014</xref>).</p>
<p>MiRNA involvement in ND development has demonstrated the capability of distinguishing between disease subtypes and shown promise for future stratification. For example in AD, 30 differentially regulated miRNAs found in the brain and blood of AD patients were assigned to different Braak stages, a methodology for classifying AD pathology, with 10 associated with Braak stage III (hsa-mir-107, hsa-mir-26b, hsa-mir-30e, hsa-mir-34a, hsa-mir-485, hsa-mir200c, hsa-mir-210, hsa-mir-146a, hsa-mir-34c, and hsa-mir-125b) (<xref ref-type="bibr" rid="B139">Swarbrick et al., 2019</xref>). Likewise in PD, miR-331-5p is differentially expressed in plasma of early onset Parkinson’s disease (EOPD) patients, which was not seen in late onset Parkinson’s disease (LOPD) patients (<xref ref-type="bibr" rid="B19">Cardo et al., 2013</xref>; <xref ref-type="table" rid="T2">Table 2</xref>). Studies comparing between subtypes of NDs are still in the minority and more are required to understand the true capability of miRNA markers in stratification of NDs.</p>
</sec>
<sec>
<title>Small Nuclear RNAs</title>
<p>Small nuclear RNAs (snRNAs), the component parts of the spliceosome – responsible for removal of non-coding introns from precursor mRNA – are highly conserved uridine rich sequences with five snRNAs making up its spine; U1, U2, U4, U5, and U6. These snRNAs combine with partner proteins to form the small nuclear ribonucleoprotein (snRNPs) complex, which is essential pre-mRNA splicing to enable production of functional mRNA for protein translation.</p>
<p>Sm-class snRNAs are synthesized by RNA polymerase II and after transcription contain a 7-methylguanosine cap, Sm-protein binding site and 3′ stem-loop. The latter two are recognized by the SMN complex, which recruits a set of Sm proteins to create the Sm-core RNP. Following this, the cap undergoes hypermethylation by trimethylguanosine synthase-1 (TSG1) creating a 2,2,7-trimethylguanosine cap. The 3′ end is then trimmed by an unknown exonuclease before subsequent maturation through modifications (<xref ref-type="bibr" rid="B106">Matera et al., 2007</xref>; <xref ref-type="fig" rid="F1">Figure 1Bi</xref>).</p>
<p>Two types of spliceosome “major” and “minor” (0.35% of all introns) can be assembled. Major spliceosome assembly commences by U1 interacting with the 5′ splice site while U2 snRNP binds to the branch point sequence. This leads to the recruitment of the premade U4/U6.U5 tri-snRNP complex, in this state the spliceosome is inactive. After destabilization or release of either U1 or U4, the spliceosome becomes active. The active spliceosome undergoes two phases of catalysis leading to its dissociation – including U2, U5, and U6 that are recycled – when it releases the mRNA, as mRNP (<xref ref-type="bibr" rid="B157">Wahl et al., 2009</xref>; <xref ref-type="fig" rid="F1">Figure 1Bii</xref>). The minor spliceosome has divergent and highly conserved 5′ splice site and branch point sequences, which interact with U5 as well as alternative factors U11, U12, and U4atac/U6atac that are functional analog of its major counterpart (<xref ref-type="bibr" rid="B154">Verma et al., 2018</xref>; <xref ref-type="fig" rid="F1">Figure 1Bii</xref>). Both spliceosomes show the capability to contribute to the development of neurodegenerative disease, demonstrating snRNA involvement (<xref ref-type="bibr" rid="B7">Bai et al., 2013</xref>; <xref ref-type="bibr" rid="B148">Tsuiji et al., 2013</xref>; <xref ref-type="bibr" rid="B118">Ratti and Buratti, 2016</xref>; <xref ref-type="bibr" rid="B74">Jutzi et al., 2018</xref>).</p>
<p>In sporadic and familial AD, U1 snRNP subunits – including U1-70K and U1A – were present in cytoplasmic aggregates, which occurs by the basic-acidic dipeptide (BAD) domain binding to tau in U1-70K (<xref ref-type="bibr" rid="B12">Bishof et al., 2018</xref>). Inordinate levels of unspliced RNA also reside, caused by dysregulation of RNA processing. In conjunction with evidence that inhibition of U1 snRNP increases APP, this implicates U1 snRNP dysregulation in the pathogenesis of AD (<xref ref-type="bibr" rid="B7">Bai et al., 2013</xref>; <xref ref-type="bibr" rid="B62">Hales et al., 2014a</xref>,<xref ref-type="bibr" rid="B63">b</xref>). Recent evidence has shown abnormal expression of U1 snRNA can cause premature cleavage of pre-mRNA via polyadenylation (PCPA) at the 3′ poly-A site. This affects splicing and could demonstrate a novel AD causing pathology (<xref ref-type="bibr" rid="B24">Cheng et al., 2017</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Interactions of small non-coding RNAs with Neurodegenerative diseases.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">sncRNA</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease</th>
<th align="center" colspan="1" rowspan="1" valign="top">Interaction</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">snRNA major spliceosome</td>
<td align="left" colspan="1" rowspan="1" valign="top">AD</td>
<td align="left" colspan="1" rowspan="1" valign="top">U1 snRNPs present in cytoplasmic aggregates</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMA</td>
<td align="left" colspan="1" rowspan="1" valign="top">SMN1 gene dysregulation alters U snRNA levels</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurodegeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top">U2snRNA mutation alters pre-mRNA splicing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ALS<break></break>FTD</td>
<td align="left" colspan="1" rowspan="1" valign="top">A disease related di-peptide repeat C90RF72 interacts with U2 snRNP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mutation found in PRPF4 which encodes U4/U6 di-snRNP protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">snRNA minor spliceosome</td>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased U12 snRNA in spinal motor neurones</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased TDP-43 disrupts U12 mediated pre-mRNA splicing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">FUS mutants cannot bind U11 so decreased minor intron splicing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">snoRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Differential expression of two C/D box snoRNAs e307 and e470 in mouse model</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNORD115 duplication in mouse causes abnormal brain development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">piRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AD</td>
<td align="left" colspan="1" rowspan="1" valign="top">9 piRNAs found to be differentially regulated in AD risk variant patients (6 APOE and 3 RNU6-560P)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PD</td>
<td align="left" colspan="1" rowspan="1" valign="top">70 differentially expressed piRNAs in combined patient tissue and cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">tsRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">ANG mutants implicated in pathogenesis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PD</td>
<td align="left" colspan="1" rowspan="1" valign="top">A subset of ALS-associated ANG mutants</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual disability</td>
<td align="left" colspan="1" rowspan="1" valign="top">NSun2 mutation causes 5′tiRNA accumulation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PCH</td>
<td align="left" colspan="1" rowspan="1" valign="top">CLP1 gene mutation disruption of tRNA splicing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurodegenerative patient</td>
<td align="left" colspan="1" rowspan="1" valign="top">KAE1 gene mutation alters tRNA modification</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>U snRNAs are also associated with spinal muscular atrophy (SMA). SMN1 gene dysregulation alters U snRNA levels through its role in U snRNA biosynthesis; nonetheless, the underlying pathology is still unclear (<xref ref-type="bibr" rid="B173">Zhang et al., 2013</xref>). Many studies have proposed a reduction in U snRNAs is key to SMA pathology due to their involvement in mRNA processing, with U1 and U11 of particular interest (<xref ref-type="bibr" rid="B48">Gabanella et al., 2007</xref>; <xref ref-type="bibr" rid="B172">Zhang et al., 2008</xref>). In contrast, U snRNAs can accumulate in the motor neurons of ALS patient spinal cords when compared to control patients, to cause defects showing that U snRNA level can depict disease state, depending of cell type (<xref ref-type="bibr" rid="B148">Tsuiji et al., 2013</xref>).</p>
<p>More recently, when considering induced pluripotent stem cell (iPSC) derived motor neurones cultures, a study suggested that an imbalanced ratio of variant U1 to U1 might cause the SMA phenotype rather than an overall reduction in U1 snRNA (<xref ref-type="bibr" rid="B153">Vazquez-Arango et al., 2016</xref>). Demonstrating that purely measuring U snRNA level may be an oversimplified measurement and variant U snRNA could indicate the underlying pathophysiology of aberrant spliceosome related neurodegeneration.</p>
<p>Other U snRNAs studied in neurodegenerative disease include U2. A U2 snRNA mutation causes neuron degeneration, through altering pre-mRNA splicing at select splice sites that are associated with alternative pre-mRNA splicing (<xref ref-type="bibr" rid="B73">Jia et al., 2012</xref>). In addition, a dipeptide repeat (C90RF72) linked to both ALS and frontotemporal dementia (FTD), interacts and interferes with U2 snRNP. In patient derived cells, this led to mislocalisation but mis-splicing linked to ALS/FTD has yet to be established (<xref ref-type="bibr" rid="B169">Yin et al., 2017</xref>).</p>
<p>Mutations found within the gene PRPF4 – which encodes hPrp4 a U4/U6 di-snRNP protein – undertake an important role in the development of retinitis pigmentosa (RP) (<xref ref-type="bibr" rid="B22">Chen et al., 2014</xref>). hPrp4 is known to interact with CypH and hPrp3 to regulate the stability of the tri-snRNP, U4/U6.U5. Thus, aberrant splicing could cause RP through direct or indirect mechanisms that have been hypothesized, but not defined.</p>
<p>The minor spliceosome has ND relevance as in ALS, TDP-43 functionality decreases (<xref ref-type="bibr" rid="B29">Colombrita et al., 2012</xref>), which reduces the number Gemini of coiled bodies (GEMs). GEMs contribute to U12 snRNA biogenesis, so in spinal motor neurones of ALS patients there was a decrease of U12 snRNA and U11/U12 snRNP, which may disrupts pre-mRNA splicing (<xref ref-type="bibr" rid="B70">Ishihara et al., 2013</xref>). Additionally, an ALS mutant (P525L) cannot promote minor intron splicing due to an aberrant FUS gene that routinely binds to U11 snRNP to direct splicing. This leads to mislocalisation of FUS-trapped U11 and U12 snRNAs, which form aggregates in the cytoplasm so incorrect splicing results (<xref ref-type="bibr" rid="B119">Reber et al., 2016</xref>). In addition, a cerebral ataxia mutation RNU12 causes minor intron retention in homozygous mutant patients (<xref ref-type="bibr" rid="B41">Elsaid et al., 2017</xref>). When combined this demonstrates a likely role for minor intron splicing in motor neurone maintenance.</p>
</sec>
<sec>
<title>Small Nucleolar RNAs</title>
<p>Small nucleolar RNAs (SnoRNAs) modify RNA through there conserved motifs, with boxes C/D guiding methylation and H/ACA guiding pseudouridylation, respectively (<xref ref-type="bibr" rid="B113">Ohtani, 2017</xref>; <xref ref-type="fig" rid="F1">Figure 1Cii</xref>). Each class of snoRNAs displays a unique secondary structure composed of conserved proteins to form the defined C/D and H/ACA snoRNPs. SnoRNAs mainly target rRNA to modify functionally important regions of the ribosome (<xref ref-type="bibr" rid="B32">Decatur and Fournier, 2002</xref>) but other purposes include pre-rRNA endonucleolytic processing (<xref ref-type="bibr" rid="B146">Tollervey and Hurt, 1990</xref>), guiding snRNAs such as U6 snRNA (<xref ref-type="bibr" rid="B149">Tycowski et al., 1998</xref>) and more recently mRNA guiding (<xref ref-type="bibr" rid="B130">Sharma et al., 2016</xref>) or regulation of alternative splicing in pre-mRNAs (<xref ref-type="bibr" rid="B42">Falaleeva et al., 2016</xref>).</p>
<p>Box C/D snoRNP biogenesis commences when a protein complex of SNU13 and NOP58 is pre-formed and loaded onto the snoRNA with the help of HSP90/R2TP. This recruits assembly factors and the pre-snoRNPs are transferred to the Cajal bodies where final processing occurs. Box H/ACA RNPs biogenesis starts by SHQ1 and DKC1 combining to prevent to non-specific RNAs binding. SHQ1 is released with the help of the R2TP complex allowing DKC1 to bind H/ACA RNAs at the site of transcription. Numerous assembly factors including NHP2, NOP10, and NAF1 are present during this pre-snoRNP form. When NAF1 – which binds the C-terminal domain of RNA polymerase II to keep H/ACA RNP inactive – is replaced by GAR1, mature and functional H/ACA RNPs are produced. Both forms are transported to the nucleolus to elicit their actions (<xref ref-type="bibr" rid="B104">Massenet et al., 2017</xref>; <xref ref-type="fig" rid="F1">Figure 1Ci</xref>).</p>
<p>A study showed differential regulation of two C/D box snoRNAs (e307 and e470) prior to the development of AD in mouse model. After formation of a β-amyloid plaque, this differential expression is no longer present, demonstrating that they could be useful in early diagnosis. No clear evidence of pathogenesis just hypothesized using bioinformatics methods (<xref ref-type="bibr" rid="B58">Gstir et al., 2014</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p>Despite the fact that autism spectrum disorder (ASD) might not be considered a neurodegenerative disease. Studies have found links in ASD with numerous snoRNA genes found to be differentially expressed using RNA-seq (<xref ref-type="bibr" rid="B162">Wright et al., 2017</xref>). Duplication of SNORD115 in mouse chromosome 7 that mirrors human chromosome 15q11-13 – duplication of this is one of the most common chromosomal abnormalities in ASD – has been shown to increase SNORD115 levels and results in abnormal brain development. In addition, SNORD115 (HBII-48 and HBII-52) levels are dysregulated in superior temporal gyrus of human ASD brain samples, which could explain 5-HT changes (<xref ref-type="bibr" rid="B49">Gabriele et al., 2014</xref>) and alternative splicing seen in ASD (<xref ref-type="bibr" rid="B156">Voineagu et al., 2011</xref>) as HBII-52 may regulate 5-HT2C receptor mRNA levels (<xref ref-type="bibr" rid="B137">Stamova et al., 2015</xref>) as well as alternative splicing (<xref ref-type="bibr" rid="B81">Kishore et al., 2010</xref>).</p>
<p>Another study demonstrated that maternal alcohol consumption in pregnancy alters the C/D box RNA levels in brain cells during abnormal fetal development. DNA methylation, microRNA and snoRNA levels altered with emphasis on SNORD115 increasing and SNORD116 decreasing (<xref ref-type="bibr" rid="B85">Laufer et al., 2013</xref>).</p>
</sec>
<sec>
<title>Piwi-Interacting RNA</title>
<p>Piwi-Interacting RNAs (PiRNAs) are a diverse range of small RNAs that are highly enriched in the germline tissues. They interact with PIWI-class Argonaute proteins with sequence bias for only the first 5′ nucleotide to be a Uracil. This diverse population can be mapped back to distinct areas of the genome known as piRNA clusters, which contain highly enriched areas of fragmented dysfunctional transposable element (TE) sequences. These are thought to emanate from the memory of previous TE invasions, and can be utilized to protect against TEs (<xref ref-type="bibr" rid="B147">Toth et al., 2016</xref>). In addition, PIWI proteins function at the chromatin level by guiding DNA methylation and deposition of repressive histone marks to silence TE transcription (<xref ref-type="bibr" rid="B86">Le Thomas et al., 2013</xref>; <xref ref-type="fig" rid="F1">Figure 1Dii</xref>).</p>
<p>The biogenesis of piRNAs gives rise to two different forms primary and secondary of 26–30 bps in length, stemming from single-stranded precursors (<xref ref-type="bibr" rid="B165">Yan et al., 2011</xref>; <xref ref-type="bibr" rid="B99">Mani and Juliano, 2013</xref>), which are best studied in Drosophila. Primary piRNAs biogenesis is poorly defined but precursors of around 200 bp stemming nearly entirely from piRNA clusters are cleaved – Zucchini (ZUC) is thought to do this – to enable loading onto a PIWI protein in association with other factors (<xref ref-type="fig" rid="F1">Figure 1Di</xref>). This piRNA-PIWI complex interacts with TEs to prevent insertion through methylation or transcriptional repression, thereby affecting gene expression (<xref ref-type="bibr" rid="B147">Toth et al., 2016</xref>).</p>
<p>In Drosophila, secondary piRNAs are formed through a more defined “ping-pong” pathway, which utilizes the primary piRNAs formed from TE fragments present in piRNA clusters loaded onto Aubergine (AUB) to find complementary antisense TE transcripts (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Once found the complementary TE mRNA binds, and is cleaved ten nucleotides along from the 5′ end by AUB, which terminates its function. Additionally it creates a new 5′ end and piRNA precursor, which accompanied by AGO3 is processed into secondary piRNA. The secondary piRNA promotes the development of more cluster-derived piRNAs – it is representative of the sense TE strand – through complementary cluster transcripts to develop a greater repertoire against active TEs (<xref ref-type="bibr" rid="B147">Toth et al., 2016</xref>; <xref ref-type="fig" rid="F1">Figure 1Di</xref>).</p>
<p>Originally piRNAs were solely thought to be present in germline cells, more recently they have been found in other areas of the body including blood (<xref ref-type="bibr" rid="B166">Yang et al., 2015</xref>), blood plasma (<xref ref-type="bibr" rid="B44">Freedman et al., 2016</xref>) and the brain (<xref ref-type="bibr" rid="B123">Roy et al., 2017</xref>) as well as interacting with diseases in the liver (<xref ref-type="bibr" rid="B122">Rizzo et al., 2016</xref>), cardiovascular system (<xref ref-type="bibr" rid="B94">Loche and Ozanne, 2016</xref>) and brain (<xref ref-type="bibr" rid="B123">Roy et al., 2017</xref>) demonstrating their roles are far-reaching. In neurodegenerative disease there have been recent studies on PD and AD.</p>
<p>Risk variants APOE (rs2075650) and RNU6-560P (rs10792835 + rs3851179) have been linked with AD through genome-wide association studies (GWAS). These risk variants were significantly correlated with nine (6 APOE and 3 RNU6-560P) different piRNAs, showing regulatory capabilities (<xref ref-type="bibr" rid="B61">Guo X. et al., 2017</xref>). PiRNA dysregulation may be integral to the development of AD through aberrant downstream signaling. The link to pathogenesis in AD was clarified in three AD dysregulated piRNAs (piR-38240, piR-34393, and piR-40666) after establishing complementary target genes (CYCS, KPNA6, and RAB11A) through inverse expression correlation (<xref ref-type="bibr" rid="B123">Roy et al., 2017</xref>). The target genes were known to regulate AD pathways through oxidative stress induced neurodegeneration, apoptosis and vesicular trafficking of Aβ. This demonstrates a regulatory role for piRNAs in preventing AD and so monitoring dysregulation could allow early diagnosis and implicate a treatment method.</p>
<p>There was a difference found in piRNA expression between PD- and control- patient derived cells. Patient tissue samples showed the same trend, with 70 different piRNAs overlapping between both (<xref ref-type="table" rid="T3">Table 3</xref>). Two distinct trends come from these piRNAs, up or down regulation (<xref ref-type="bibr" rid="B127">Schulze et al., 2018</xref>). In the down-regulated piRNA fraction, those that were short-interspersed nuclear elements (SINE) and long-interspersed nuclear elements (LINE) derived elements in cell lines and LINE in tissues, showed significant enrichment when compared to genome-wide expression (<xref ref-type="bibr" rid="B127">Schulze et al., 2018</xref>). This is indicative of an inability to silence SINE and LINE derived elements in PD-derived neurones, which could show a pathogenesis of PD disease.</p>
</sec>
<sec>
<title>Transfer RNAs</title>
<p>Transfer RNAs (tRNAs) are the most abundant form of sncRNA, making up 4–10% of all cellular RNAs. Previously thought to be static contributors to gene expression, acting as an adaptor molecule in translation. Recently it has been found that small non-coding tRNAs have unique function that enable wider signaling and dynamic regulation of various functions (<xref ref-type="bibr" rid="B52">Gebetsberger and Polacek, 2013</xref>).</p>
<p>Mature tRNA is formed through transcription of precursor tRNA (pre-tRNA) using RNA polymerase III. Endonucleolytic ribonuclease P (RNase P) and ribonuclease Z cleave the transcribed pre-tRNA at the 5′ leader sequence and 3′ polyuracil (poly –U) tail, respectively, before tRNA nucleotidyl transferase adds a 3′CCA tail (<xref ref-type="fig" rid="F1">Figure 1Ei</xref>). Many post-transcriptional modifications will occur during maturation and only tRNAs appropriately processed will leave the nucleus via nuclear receptor-mediated export process, with wrongly processed terminating. The mature tRNAs are between 73–90 nts in length and contain a clover-leaf shaped secondary structure, composing of a D-loop, an anticodon loop, a T-loop, a variable loop and an amino acid acceptor stem (<xref ref-type="bibr" rid="B80">Kirchner and Ignatova, 2015</xref>). The mature of pre-tRNA can be cleaved – into specific products unlike previously thought – into two main categories of cleaved tRNAs have been categorized; (1) tRNA-halves, (2) tRNA derived fragments.</p>
<p>tRNA halves are produced by cleavage of the anticodon loop giving rise to two halves; 30–35 nt 5′-tRNA halves and 40–50 nt 3′tRNA halves (<xref ref-type="bibr" rid="B90">Li and Hu, 2012</xref>; <xref ref-type="fig" rid="F1">Figure 1Eii</xref>). A subtype of tRNA halves known as tRNA-derived stress-induced RNAs (tiRNAs) are by-products of stress. They induce cleavage by angiogenin (ANG) – a ribonuclease – of mature cytoplasmic tRNAs (<xref ref-type="bibr" rid="B164">Yamasaki et al., 2009</xref>).</p>
<p>tRNA derived fragments (tRFs) are produced from either pre-tRNAs or mature tRNAs (<xref ref-type="fig" rid="F1">Figure 1Eii</xref>). Four main types have been established stemming from the fragment location on tRNAs: 5-tRFs, 3-tRFs, 1-tRFs, and 2 tRFs. 5-tRFs – located most abundantly in the nucleus – are generated from cleavage of the D-loop of tRNAs by Dicer, with adenine being present at the 3′ ends. Further subdivision classifies 5-tRFs isoforms into “a” (∼15 nts), “b” (∼22 nts) and “c” (∼30 nts) (<xref ref-type="bibr" rid="B83">Kumar et al., 2015</xref>; <xref ref-type="bibr" rid="B87">Lee et al., 2009</xref>). 3-tRFs result from cleavage by Dicer, ANG or another member of the Ribonuclease A superfamily of the T-loop, containing a CCA tail sequence (18–22 nts) (<xref ref-type="bibr" rid="B87">Lee et al., 2009</xref>; <xref ref-type="bibr" rid="B100">Maraia and Lamichhane, 2011</xref>; <xref ref-type="bibr" rid="B83">Kumar et al., 2015</xref>). 1-tRFs are formed by the cleavage of the 3′-trailer fragment of pre-tRNAs by either RNaseZ or ELAC2, this usually commences after the 3′-ends of mature tRNA and contains a poly-U 3′-end (<xref ref-type="bibr" rid="B87">Lee et al., 2009</xref>; <xref ref-type="bibr" rid="B91">Liao et al., 2010</xref>). 2-tRFs, less known about but may be formed from the anticodon loop (<xref ref-type="bibr" rid="B54">Goodarzi et al., 2015</xref>).</p>
<p>Numerous neurodegenerative disorders are associated with tRFs. ANG mutants show reduced ribonuclease (RNase) activity and were first implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="B56">Greenway et al., 2006</xref>). Latterly, a subset of the ALS-associated ANG mutants were observed in Parkinson’s disease (PD) patients (<xref ref-type="bibr" rid="B152">van Es et al., 2011</xref>). Recombinant ANG can improve life span and motor function in an ALS [SOD1 (G93A)] mouse model, demonstrating that tRFs may have an important role in motor neuron survival (<xref ref-type="bibr" rid="B78">Kieran et al., 2008</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p>The link between ANG-induced tiRNAs, cellular stress and neurodevelopment disorders was strengthened with the finding of NSun2 (<xref ref-type="bibr" rid="B13">Blanco et al., 2014</xref>). Mutations in the cytosine-5 RNA methyltransferase NSun2 have been shown to cause intellectual disability and a Dubowitz-like syndrome in humans (<xref ref-type="bibr" rid="B1">Abbasi-Moheb et al., 2012</xref>; <xref ref-type="bibr" rid="B102">Martinez et al., 2012</xref>). NSun2 methylates two different cytosine residues of tRNA. Without NSun2, cytosine-5 RNAs are not methylated, which increases the stress-induced ANG-mediated endonucleolytic cleavage of tRNAs and so 5′-tiRNAs accumulate. Accumulation of these factors leads to cell death in hippocampal and striatal neurons because of translational repression leading to cellular stress. Subsequently, NSun2 knockout mice show reduced neuronal size and impaired formation of synapses, which could explain the impairment of NSun2 gene mutation patients (<xref ref-type="bibr" rid="B13">Blanco et al., 2014</xref>).</p>
<p>A mutation in CLP1 gene (R140A) – a RNA kinase involved in tRNA splicing – is present in pontocerebellar hypoplasia (PCH) patients, a heterogeneous group of inherited neurodegenerative disorders characterized by the loss of motor neurons, muscle paralysis, impaired development of various parts of the brain and differential tRNA splicing (<xref ref-type="bibr" rid="B75">Karaca et al., 2014</xref>; <xref ref-type="bibr" rid="B125">Schaffer et al., 2014</xref>). The role of CLP1 in RNA splicing means the mutant gene has reduced kinase activity and affinity to the tRNA endonuclease complex (TSEN), impairing pre-tRNA cleavage and elevating unspliced pre-tRNAs in patient derived neurons (<xref ref-type="bibr" rid="B125">Schaffer et al., 2014</xref>). TSEN cuts the transcript at 3′ intron-extron junctions, so the absence of CLP1 means 5′-unphosphorylated tRF cannot interact with the pre-tRNA<sup>tyr</sup> 3′-exon and subsequent splicing steps are interrupted (<xref ref-type="bibr" rid="B21">Cassandrini et al., 2010</xref>).</p>
<p>N<sup>6</sup>-threonyl-carbamoyl-adenosine (t<sup>6</sup>A) is a complex modification of adenosine involved in cytoplasmic tRNA modification. It is located next to the anticodon loop of many tRNAs that decode ANN codons, at position 37 (t<sup>6</sup>A37). Recently, a biosynthetic defect in the t<sup>6</sup>A molecule resulting from a mutation in the kinase-associated endopeptidase (KAE1) gene, which is part of the kinase, endopeptidase and other proteins of small size (KEOPS) complex was found in two phenotypically neurodegenerative patients, implicating tRNA modification in neuronal maintenance (<xref ref-type="bibr" rid="B40">Edvardson et al., 2017</xref>).</p>
<p>Although, tRNA-derived small non-coding RNAs, have already demonstrated a role in cancer progression (<xref ref-type="bibr" rid="B138">Sun et al., 2018</xref>), their role as biomarkers in NDs has not been fully investigated yet.</p>
<p>However, animal studies showed 13 dysregulated tRFs in brain samples of SAMP8 mouse model for AD. In particular, four were upregulated (AS-tDR-011775, AS-tDR-011438, AS-tDR-006835 and AStDR-005058) and 9 down regulated (AS-tDR-013428, AS-tDR-011389, AS-tDR-009392, AS-tDR012690, AS-tDR-010654, AS-tDR-008616, AS-tDR-010789, AS-tDR-011670, and AS-tDR-007919), demonstrating their potential involvement of tRFs in early detection of AD.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The key problem with the ND field is the lack of understanding in the events preceding the development of protein-based markers – such as Tau – currently used to diagnose NDs. By this stage, the diseases become more difficult to treat.</p>
<p>SncRNAs play an important regulatory role in the maintenance of the homeostatic brain. Therefore, changes in their concentration levels can be indicative of mechanistic changes that could precede protein-based markers. One single sncRNA biomarker is unlikely to differentiate between diseases. However, a combination of sncRNA biomarkers could be illustrative of the mechanistic development of NDs to enable early diagnosis, enhanced disease monitoring as well as defining subtle differences between NDs. Consequently, novel treatment methods directly related to their mechanistic underpinning of specific NDs, and potentially other brain related pathologies can be envisaged.</p>
<p>Novel, less-well studied sncRNAs could be integral to understanding the overall disease progression. So new methodologies may be necessary to quantify these changes and allow for future biomarker development.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>CW drafted the manuscript. AB and VDP critically revised the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi-Moheb</surname><given-names>L.</given-names></name><name><surname>Mertel</surname><given-names>S.</given-names></name><name><surname>Gonsior</surname><given-names>M.</given-names></name><name><surname>Nouri-Vahid</surname><given-names>L.</given-names></name><name><surname>Kahrizi</surname><given-names>K.</given-names></name><name><surname>Cirak</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in NSUN2 cause autosomal-recessive intellectual disability.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>847</fpage>–<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.021</pub-id>
<pub-id pub-id-type="pmid">22541559</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Absalon</surname><given-names>S.</given-names></name><name><surname>Kochanek</surname><given-names>D. M.</given-names></name><name><surname>Raghavan</surname><given-names>V.</given-names></name><name><surname>Krichevsky</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>MiR-26b, upregulated in Alzheimer’s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>14645</fpage>–<lpage>14659</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1327-13.2013</pub-id><pub-id pub-id-type="pmid">24027266</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>M.</given-names></name><name><surname>Biswas</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Molecular diagnostics of neurodegenerative disorders.</article-title>
<source/><italic>Front. Mol. Biosci.</italic>
<volume>2</volume>:<issue>54</issue>
<pub-id pub-id-type="doi">10.3389/fmolb.2015.00054</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrov</surname><given-names>P. N.</given-names></name><name><surname>Dua</surname><given-names>P.</given-names></name><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Bhattacharjee</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2012</year>). <article-title>microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).</article-title>
<source/><italic>Int. J. Biochem. Mol. Biol.</italic>
<volume>3</volume>
<fpage>365</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">23301201</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Erviti</surname><given-names>L.</given-names></name><name><surname>Seow</surname><given-names>Y.</given-names></name><name><surname>Schapira</surname><given-names>A. H.</given-names></name><name><surname>Rodriguez-Oroz</surname><given-names>M. C.</given-names></name><name><surname>Obeso</surname><given-names>J. A.</given-names></name><name><surname>Cooper</surname><given-names>J. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson’s disease.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>4</volume>:<issue>e545</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2013.73</pub-id>
<pub-id pub-id-type="pmid">23492776</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronin</surname><given-names>N.</given-names></name><name><surname>DiFiglia</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Huntingtin-lowering strategies in Huntington’s disease: antisense oligonucleotides, small RNAs, and gene editing.</article-title>
<source/><italic>Mov. Disord.</italic>
<volume>29</volume>
<fpage>1455</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26020</pub-id>
<pub-id pub-id-type="pmid">25164989</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>B.</given-names></name><name><surname>Hales</surname><given-names>C. M.</given-names></name><name><surname>Chen</surname><given-names>P. C.</given-names></name><name><surname>Gozal</surname><given-names>Y.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Fritz</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>16562</fpage>–<lpage>16567</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1310249110</pub-id>
<pub-id pub-id-type="pmid">24023061</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Ni</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>5411</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-03887-3</pub-id>
<pub-id pub-id-type="pmid">28710399</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekris</surname><given-names>L. M.</given-names></name><name><surname>Lutz</surname><given-names>F.</given-names></name><name><surname>Montine</surname><given-names>T. J.</given-names></name><name><surname>Yu</surname><given-names>C. E.</given-names></name><name><surname>Tsuang</surname><given-names>D.</given-names></name><name><surname>Peskind</surname><given-names>E. R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>MicroRNA in Alzheimer’s disease: an exploratory study in brain, cerebrospinal fluid and plasma.</article-title>
<source/><italic>Biomarkers</italic>
<volume>18</volume>
<fpage>455</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.3109/1354750x.2013.814073</pub-id>
<pub-id pub-id-type="pmid">23822153</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benigni</surname><given-names>M.</given-names></name><name><surname>Ricci</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>A. R.</given-names></name><name><surname>Giannini</surname><given-names>F.</given-names></name><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name><name><surname>Battistini</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients.</article-title>
<source/><italic>Neuromolecular Med.</italic>
<volume>18</volume>
<fpage>551</fpage>–<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-016-8396-8</pub-id>
<pub-id pub-id-type="pmid">27119371</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatnagar</surname><given-names>S.</given-names></name><name><surname>Chertkow</surname><given-names>H.</given-names></name><name><surname>Schipper</surname><given-names>H. M.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Shetty</surname><given-names>V.</given-names></name><name><surname>Jenkins</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Increased microRNA-34c abundance in Alzheimer’s disease circulating blood plasma.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>7</volume>:<issue>2</issue>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00002</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishof</surname><given-names>I.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Duong</surname><given-names>D. M.</given-names></name><name><surname>Kundinger</surname><given-names>S. R.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><name><surname>Lah</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer’s disease.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>293</volume>
<fpage>11047</fpage>–<lpage>11066</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA118.001747</pub-id>
<pub-id pub-id-type="pmid">29802200</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>S.</given-names></name><name><surname>Dietmann</surname><given-names>S.</given-names></name><name><surname>Flores</surname><given-names>J. V.</given-names></name><name><surname>Hussain</surname><given-names>S.</given-names></name><name><surname>Kutter</surname><given-names>C.</given-names></name><name><surname>Humphreys</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.</article-title>
<source/><italic>EMBO J.</italic>
<volume>33</volume>
<fpage>2020</fpage>–<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201489282</pub-id>
<pub-id pub-id-type="pmid">25063673</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botta-Orfila</surname><given-names>T.</given-names></name><name><surname>Morato</surname><given-names>X.</given-names></name><name><surname>Compta</surname><given-names>Y.</given-names></name><name><surname>Lozano</surname><given-names>J. J.</given-names></name><name><surname>Falgas</surname><given-names>N.</given-names></name><name><surname>Valldeoriola</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson’s disease.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>92</volume>
<fpage>1071</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23377</pub-id>
<pub-id pub-id-type="pmid">24648008</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgos</surname><given-names>K.</given-names></name><name><surname>Malenica</surname><given-names>I.</given-names></name><name><surname>Metpally</surname><given-names>R.</given-names></name><name><surname>Courtright</surname><given-names>A.</given-names></name><name><surname>Rakela</surname><given-names>B.</given-names></name><name><surname>Beach</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e94839</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094839</pub-id>
<pub-id pub-id-type="pmid">24797360</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Siddiqui</surname><given-names>S.</given-names></name><name><surname>Gabriely</surname><given-names>G.</given-names></name><name><surname>Lanser</surname><given-names>A. J.</given-names></name><name><surname>Dake</surname><given-names>B.</given-names></name><name><surname>Murugaiyan</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>122</volume>
<fpage>3063</fpage>–<lpage>3087</lpage>. <pub-id pub-id-type="doi">10.1172/jci62636</pub-id>
<pub-id pub-id-type="pmid">22863620</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caggiu</surname><given-names>E.</given-names></name><name><surname>Paulus</surname><given-names>K.</given-names></name><name><surname>Mameli</surname><given-names>G.</given-names></name><name><surname>Arru</surname><given-names>G.</given-names></name><name><surname>Sechi</surname><given-names>G. P.</given-names></name><name><surname>Sechi</surname><given-names>L. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Differential expression of miRNA 155 and miRNA 146a in Parkinson’s disease patients.</article-title>
<source/><italic>eNeurologicalSci</italic>
<volume>13</volume>
<fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.ensci.2018.09.002</pub-id>
<pub-id pub-id-type="pmid">30255159</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calin</surname><given-names>G. A.</given-names></name><name><surname>Croce</surname><given-names>C. M.</given-names></name></person-group> (<year>2006</year>). <article-title>MicroRNA signatures in human cancers.</article-title>
<source/><italic>Nat. Rev. Cancer</italic>
<volume>6</volume>
<fpage>857</fpage>–<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1038/nrc1997</pub-id>
<pub-id pub-id-type="pmid">17060945</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardo</surname><given-names>L. F.</given-names></name><name><surname>Coto</surname><given-names>E.</given-names></name><name><surname>de Mena</surname><given-names>L.</given-names></name><name><surname>Ribacoba</surname><given-names>R.</given-names></name><name><surname>Moris</surname><given-names>G.</given-names></name><name><surname>Menendez</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls.</article-title>
<source/><italic>J. Neurol.</italic>
<volume>260</volume>
<fpage>1420</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-013-6900-8</pub-id>
<pub-id pub-id-type="pmid">23543376</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardo</surname><given-names>L. F.</given-names></name><name><surname>Coto</surname><given-names>E.</given-names></name><name><surname>Ribacoba</surname><given-names>R.</given-names></name><name><surname>Menendez</surname><given-names>M.</given-names></name><name><surname>Moris</surname><given-names>G.</given-names></name><name><surname>Suarez</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>MiRNA profile in the substantia nigra of Parkinson’s disease and healthy subjects.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>54</volume>
<fpage>830</fpage>–<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-014-0428-y</pub-id>
<pub-id pub-id-type="pmid">25284245</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassandrini</surname><given-names>D.</given-names></name><name><surname>Biancheri</surname><given-names>R.</given-names></name><name><surname>Tessa</surname><given-names>A.</given-names></name><name><surname>Di Rocco</surname><given-names>M.</given-names></name><name><surname>Di Capua</surname><given-names>M.</given-names></name><name><surname>Bruno</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies.</article-title>
<source/><italic>Neurology</italic>
<volume>75</volume>
<fpage>1459</fpage>–<lpage>1464</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f88173</pub-id>
<pub-id pub-id-type="pmid">20956791</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>X.</given-names></name><name><surname>Tam</surname><given-names>P. O.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>PRPF4 mutations cause autosomal dominant retinitis pigmentosa.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>2926</fpage>–<lpage>2939</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu005</pub-id>
<pub-id pub-id-type="pmid">24419317</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Doecke</surname><given-names>J. D.</given-names></name><name><surname>Sharples</surname><given-names>R. A.</given-names></name><name><surname>Villemagne</surname><given-names>V. L.</given-names></name><name><surname>Fowler</surname><given-names>C. J.</given-names></name><name><surname>Rembach</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>20</volume>
<fpage>1188</fpage>–<lpage>1196</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.127</pub-id>
<pub-id pub-id-type="pmid">25349172</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Shang</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer’s disease.</article-title>
<source/><italic>J. Neurogenet.</italic>
<volume>31</volume>
<fpage>337</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1080/01677063.2017.1395425</pub-id>
<pub-id pub-id-type="pmid">29098922</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H. J.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>S. M.</given-names></name><name><surname>Parisiadou</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>MicroRNA-205 regulates the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 protein.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>608</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds470</pub-id>
<pub-id pub-id-type="pmid">23125283</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Sonntag</surname><given-names>K. C.</given-names></name><name><surname>Andersson</surname><given-names>T.</given-names></name><name><surname>Bjorklund</surname><given-names>L. M.</given-names></name><name><surname>Park</surname><given-names>J. J.</given-names></name><name><surname>Kim</surname><given-names>D. W.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>16</volume>
<fpage>1829</fpage>–<lpage>1838</lpage>. <pub-id pub-id-type="pmid">12453046</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciurleo</surname><given-names>R.</given-names></name><name><surname>Di Lorenzo</surname><given-names>G.</given-names></name><name><surname>Bramanti</surname><given-names>P.</given-names></name><name><surname>Marino</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson’s disease?</article-title>
<source/><italic>Biomed Res. Int.</italic>
<volume>2014</volume>:<issue>519816</issue>. <pub-id pub-id-type="doi">10.1155/2014/519816</pub-id>
<pub-id pub-id-type="pmid">25302300</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogswell</surname><given-names>J. P.</given-names></name><name><surname>Ward</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>I. A.</given-names></name><name><surname>Waters</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Cannon</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>14</volume>
<fpage>27</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">18525125</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombrita</surname><given-names>C.</given-names></name><name><surname>Onesto</surname><given-names>E.</given-names></name><name><surname>Megiorni</surname><given-names>F.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><name><surname>Baralle</surname><given-names>F. E.</given-names></name><name><surname>Buratti</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>15635</fpage>–<lpage>15647</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.333450</pub-id>
<pub-id pub-id-type="pmid">22427648</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Andrade</surname><given-names>H. M.</given-names></name><name><surname>de Albuquerque</surname><given-names>M.</given-names></name><name><surname>Avansini</surname><given-names>S. H.</given-names></name><name><surname>de</surname><given-names>S. R. C.</given-names></name><name><surname>Dogini</surname><given-names>D. B.</given-names></name><name><surname>Nucci</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>368</volume>
<fpage>19</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2016.06.046</pub-id>
<pub-id pub-id-type="pmid">27538595</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>B.</given-names></name><name><surname>Annunziata</surname><given-names>A.</given-names></name><name><surname>Fiorentino</surname><given-names>G.</given-names></name><name><surname>Borra</surname><given-names>M.</given-names></name><name><surname>Biffali</surname><given-names>E.</given-names></name><name><surname>Coppola</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>15</volume>
<fpage>243</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-014-0420-2</pub-id>
<pub-id pub-id-type="pmid">25130371</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decatur</surname><given-names>W. A.</given-names></name><name><surname>Fournier</surname><given-names>M. J.</given-names></name></person-group> (<year>2002</year>). <article-title>rRNA modifications and ribosome function.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>27</volume>
<fpage>344</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">12114023</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denk</surname><given-names>J.</given-names></name><name><surname>Boelmans</surname><given-names>K.</given-names></name><name><surname>Siegismund</surname><given-names>C.</given-names></name><name><surname>Lassner</surname><given-names>D.</given-names></name><name><surname>Arlt</surname><given-names>S.</given-names></name><name><surname>Jahn</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer’s disease.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0126423</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0126423</pub-id>
<pub-id pub-id-type="pmid">25992776</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>V.</given-names></name><name><surname>Ragusa</surname><given-names>M.</given-names></name><name><surname>Davies</surname><given-names>D.</given-names></name><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Hazeldine</surname><given-names>J.</given-names></name><name><surname>Lazzarino</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury.</article-title>
<source/><italic>J. Neurotrauma</italic>
<volume>34</volume>
<fpage>1948</fpage>–<lpage>1956</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2016.4857</pub-id>
<pub-id pub-id-type="pmid">28279125</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Planelles</surname><given-names>C.</given-names></name><name><surname>Sanchez-Lozano</surname><given-names>P.</given-names></name><name><surname>Crespo</surname><given-names>M. C.</given-names></name><name><surname>Gil-Zamorano</surname><given-names>J.</given-names></name><name><surname>Ribacoba</surname><given-names>R.</given-names></name><name><surname>Gonzalez</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Circulating microRNAs in Huntington’s disease: emerging mediators in metabolic impairment.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>108</volume>
<fpage>102</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2016.05.005</pub-id>
<pub-id pub-id-type="pmid">27155059</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Identification of a panel of five serum miRNAs as a biomarker for Parkinson’s disease.</article-title>
<source/><italic>Parkinsonism Relat. Disord.</italic>
<volume>22</volume>
<fpage>68</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.11.014</pub-id>
<pub-id pub-id-type="pmid">26631952</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease.</article-title>
<source/><italic>Dis. Markers</italic>
<volume>2015</volume>:<issue>625659</issue>. <pub-id pub-id-type="doi">10.1155/2015/625659</pub-id>
<pub-id pub-id-type="pmid">26078483</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease.</article-title>
<source/><italic>Biomarkers</italic>
<volume>21</volume>
<fpage>129</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.3109/1354750x.2015.1118544</pub-id>
<pub-id pub-id-type="pmid">26631297</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>M. G.</given-names></name><name><surname>Giles</surname><given-names>C. B.</given-names></name><name><surname>Koelsch</surname><given-names>K. A.</given-names></name><name><surname>Wren</surname><given-names>J. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Systematic classification of non-coding RNAs by epigenomic similarity.</article-title>
<source/><italic>BMC Bioinformatics</italic>
<volume>14</volume>(Suppl. 14):<issue>S2</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-S14-S2</pub-id>
<pub-id pub-id-type="pmid">24267974</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvardson</surname><given-names>S.</given-names></name><name><surname>Prunetti</surname><given-names>L.</given-names></name><name><surname>Arraf</surname><given-names>A.</given-names></name><name><surname>Haas</surname><given-names>D.</given-names></name><name><surname>Bacusmo</surname><given-names>J. M.</given-names></name><name><surname>Hu</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>tRNA N6-adenosine threonylcarbamoyltransferase defect due to KAE1/TCS3 (OSGEP) mutation manifest by neurodegeneration and renal tubulopathy.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>25</volume>
<fpage>545</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2017.30</pub-id>
<pub-id pub-id-type="pmid">28272532</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsaid</surname><given-names>M. F.</given-names></name><name><surname>Chalhoub</surname><given-names>N.</given-names></name><name><surname>Ben-Omran</surname><given-names>T.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Kamel</surname><given-names>H.</given-names></name><name><surname>Ibrahim</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>81</volume>
<fpage>68</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24826</pub-id>
<pub-id pub-id-type="pmid">27863452</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falaleeva</surname><given-names>M.</given-names></name><name><surname>Pages</surname><given-names>A.</given-names></name><name><surname>Matuszek</surname><given-names>Z.</given-names></name><name><surname>Hidmi</surname><given-names>S.</given-names></name><name><surname>Agranat-Tamir</surname><given-names>L.</given-names></name><name><surname>Korotkov</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E1625</fpage>–<lpage>E1634</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1519292113</pub-id>
<pub-id pub-id-type="pmid">26957605</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fransquet</surname><given-names>P. D.</given-names></name><name><surname>Ryan</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer’s disease.</article-title>
<source/><italic>Clin. Biochem.</italic>
<volume>58</volume>
<fpage>5</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2018.05.020</pub-id>
<pub-id pub-id-type="pmid">29885309</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>J. E.</given-names></name><name><surname>Gerstein</surname><given-names>M.</given-names></name><name><surname>Mick</surname><given-names>E.</given-names></name><name><surname>Rozowsky</surname><given-names>J.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Kitchen</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Diverse human extracellular RNAs are widely detected in human plasma.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>11106</issue>. <pub-id pub-id-type="doi">10.1038/ncomms11106</pub-id>
<pub-id pub-id-type="pmid">27112789</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freischmidt</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Ludolph</surname><given-names>A. C.</given-names></name><name><surname>Weishaupt</surname><given-names>J. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>1</volume>:<issue>42</issue>. <pub-id pub-id-type="doi">10.1186/2051-5960-1-42</pub-id>
<pub-id pub-id-type="pmid">24252274</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freischmidt</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Zondler</surname><given-names>L.</given-names></name><name><surname>Weydt</surname><given-names>P.</given-names></name><name><surname>Mayer</surname><given-names>B.</given-names></name><name><surname>von Arnim</surname><given-names>C. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Serum microRNAs in sporadic amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>36</volume>
<fpage>2660.e15</fpage>–<lpage>2660.e20</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.06.003</pub-id>
<pub-id pub-id-type="pmid">26142125</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freischmidt</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Zondler</surname><given-names>L.</given-names></name><name><surname>Weydt</surname><given-names>P.</given-names></name><name><surname>Volk</surname><given-names>A. E.</given-names></name><name><surname>Bozic</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.</article-title>
<source/><italic>Brain</italic>
<volume>137</volume>
<fpage>2938</fpage>–<lpage>2950</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu249</pub-id>
<pub-id pub-id-type="pmid">25193138</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabanella</surname><given-names>F.</given-names></name><name><surname>Butchbach</surname><given-names>M. E.</given-names></name><name><surname>Saieva</surname><given-names>L.</given-names></name><name><surname>Carissimi</surname><given-names>C.</given-names></name><name><surname>Burghes</surname><given-names>A. H.</given-names></name><name><surname>Pellizzoni</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.</article-title>
<source/><italic>PLoS One</italic>
<volume>2</volume>:<issue>e921</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0000921</pub-id>
<pub-id pub-id-type="pmid">17895963</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabriele</surname><given-names>S.</given-names></name><name><surname>Sacco</surname><given-names>R.</given-names></name><name><surname>Persico</surname><given-names>A. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>24</volume>
<fpage>919</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.02.004</pub-id>
<pub-id pub-id-type="pmid">24613076</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galimberti</surname><given-names>D.</given-names></name><name><surname>Villa</surname><given-names>C.</given-names></name><name><surname>Fenoglio</surname><given-names>C.</given-names></name><name><surname>Serpente</surname><given-names>M.</given-names></name><name><surname>Ghezzi</surname><given-names>L.</given-names></name><name><surname>Cioffi</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Circulating miRNAs as potential biomarkers in Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>42</volume>
<fpage>1261</fpage>–<lpage>1267</lpage>. <pub-id pub-id-type="doi">10.3233/jad-140756</pub-id>
<pub-id pub-id-type="pmid">25024331</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaughwin</surname><given-names>P. M.</given-names></name><name><surname>Ciesla</surname><given-names>M.</given-names></name><name><surname>Lahiri</surname><given-names>N.</given-names></name><name><surname>Tabrizi</surname><given-names>S. J.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Bjorkqvist</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington’s disease.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>2225</fpage>–<lpage>2237</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr111</pub-id>
<pub-id pub-id-type="pmid">21421997</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebetsberger</surname><given-names>J.</given-names></name><name><surname>Polacek</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Slicing tRNAs to boost functional ncRNA diversity.</article-title>
<source/><italic>RNA Biol.</italic>
<volume>10</volume>
<fpage>1798</fpage>–<lpage>1806</lpage>. <pub-id pub-id-type="doi">10.4161/rna.27177</pub-id>
<pub-id pub-id-type="pmid">24351723</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geekiyanage</surname><given-names>H.</given-names></name><name><surname>Jicha</surname><given-names>G. A.</given-names></name><name><surname>Nelson</surname><given-names>P. T.</given-names></name><name><surname>Chan</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>235</volume>
<fpage>491</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.11.026</pub-id>
<pub-id pub-id-type="pmid">22155483</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Nguyen</surname><given-names>H. C.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Fish</surname><given-names>L.</given-names></name><name><surname>Tavazoie</surname><given-names>S. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement.</article-title>
<source/><italic>Cell</italic>
<volume>161</volume>
<fpage>790</fpage>–<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.02.053</pub-id>
<pub-id pub-id-type="pmid">25957686</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grasso</surname><given-names>M.</given-names></name><name><surname>Piscopo</surname><given-names>P.</given-names></name><name><surname>Confaloni</surname><given-names>A.</given-names></name><name><surname>Denti</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Circulating miRNAs as biomarkers for neurodegenerative disorders.</article-title>
<source/><italic>Molecules</italic>
<volume>19</volume>
<fpage>6891</fpage>–<lpage>6910</lpage>. <pub-id pub-id-type="doi">10.3390/molecules19056891</pub-id>
<pub-id pub-id-type="pmid">24858274</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenway</surname><given-names>M. J.</given-names></name><name><surname>Andersen</surname><given-names>P. M.</given-names></name><name><surname>Russ</surname><given-names>C.</given-names></name><name><surname>Ennis</surname><given-names>S.</given-names></name><name><surname>Cashman</surname><given-names>S.</given-names></name><name><surname>Donaghy</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>ANG mutations segregate with familial and ’sporadic’ amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>38</volume>
<fpage>411</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1038/ng1742</pub-id>
<pub-id pub-id-type="pmid">16501576</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groiss</surname><given-names>S. J.</given-names></name><name><surname>Wojtecki</surname><given-names>L.</given-names></name><name><surname>Südmeyer</surname><given-names>M.</given-names></name><name><surname>Schnitzler</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Review: deep brain stimulation in Parkinson’s disease.</article-title>
<source/><italic>Ther. Adv. Neurol. Disord.</italic>
<volume>2</volume>
<fpage>20</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1177/1756285609339382</pub-id>
<pub-id pub-id-type="pmid">21180627</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gstir</surname><given-names>R.</given-names></name><name><surname>Schafferer</surname><given-names>S.</given-names></name><name><surname>Scheideler</surname><given-names>M.</given-names></name><name><surname>Misslinger</surname><given-names>M.</given-names></name><name><surname>Griehl</surname><given-names>M.</given-names></name><name><surname>Daschil</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases.</article-title>
<source/><italic>RNA</italic>
<volume>20</volume>
<fpage>1929</fpage>–<lpage>1943</lpage>. <pub-id pub-id-type="doi">10.1261/rna.047225.114</pub-id>
<pub-id pub-id-type="pmid">25344396</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.</article-title>
<source/><italic>Oncotarget</italic>
<volume>6</volume>
<fpage>37043</fpage>–<lpage>37053</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.6158</pub-id>
<pub-id pub-id-type="pmid">26497684</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>60</volume>
<fpage>1365</fpage>–<lpage>1377</lpage>. <pub-id pub-id-type="doi">10.3233/jad-170343</pub-id>
<pub-id pub-id-type="pmid">29036818</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Qiu</surname><given-names>W.</given-names></name><name><surname>Garcia-Milian</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genome-wide significant, replicated and functional risk variants for Alzheimer’s disease.</article-title>
<source/><italic>J. Neural Transm.</italic>
<volume>124</volume>
<fpage>1455</fpage>–<lpage>1471</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-017-1773-0</pub-id>
<pub-id pub-id-type="pmid">28770390</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>C. M.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Diner</surname><given-names>I.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Seyfried</surname><given-names>N. T.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014a</year>). <article-title>Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer’s disease.</article-title>
<source/><italic>Brain Pathol.</italic>
<volume>24</volume>
<fpage>344</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12133</pub-id>
<pub-id pub-id-type="pmid">24571648</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>C. M.</given-names></name><name><surname>Seyfried</surname><given-names>N. T.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Duong</surname><given-names>D.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014b</year>). <article-title>U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>9</volume>:<issue>15</issue>. <pub-id pub-id-type="doi">10.1186/1750-1326-9-15</pub-id>
<pub-id pub-id-type="pmid">24773620</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>N.</given-names></name><name><surname>Kikuchi</surname><given-names>M.</given-names></name><name><surname>Miyashita</surname><given-names>A.</given-names></name><name><surname>Hatsuta</surname><given-names>H.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Kasuga</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>5</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.1186/s40478-017-0414-z</pub-id>
<pub-id pub-id-type="pmid">28137310</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>S. S.</given-names></name><name><surname>Horre</surname><given-names>K.</given-names></name><name><surname>Nicolai</surname><given-names>L.</given-names></name><name><surname>Papadopoulou</surname><given-names>A. S.</given-names></name><name><surname>Mandemakers</surname><given-names>W.</given-names></name><name><surname>Silahtaroglu</surname><given-names>A. N.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>6415</fpage>–<lpage>6420</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0710263105</pub-id>
<pub-id pub-id-type="pmid">18434550</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heemels</surname><given-names>M. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurodegenerative diseases.</article-title>
<source/><italic>Nature</italic>
<volume>539</volume>:<issue>179</issue>. <pub-id pub-id-type="doi">10.1038/539179a</pub-id>
<pub-id pub-id-type="pmid">27830810</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoss</surname><given-names>A. G.</given-names></name><name><surname>Labadorf</surname><given-names>A.</given-names></name><name><surname>Beach</surname><given-names>T. G.</given-names></name><name><surname>Latourelle</surname><given-names>J. C.</given-names></name><name><surname>Myers</surname><given-names>R. H.</given-names></name></person-group> (<year>2016</year>). <article-title>microRNA profiles in Parkinson’s disease prefrontal cortex.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>8</volume>:<issue>36</issue>
<pub-id pub-id-type="doi">10.3389/fnagi.2016.00036</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoss</surname><given-names>A. G.</given-names></name><name><surname>Labadorf</surname><given-names>A.</given-names></name><name><surname>Latourelle</surname><given-names>J. C.</given-names></name><name><surname>Kartha</surname><given-names>V. K.</given-names></name><name><surname>Hadzi</surname><given-names>T. C.</given-names></name><name><surname>Gusella</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2015a</year>). <article-title>miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement.</article-title>
<source/><italic>BMC Med. Genomics</italic>
<volume>8</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.1186/s12920-015-0083-3</pub-id>
<pub-id pub-id-type="pmid">25889241</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoss</surname><given-names>A. G.</given-names></name><name><surname>Lagomarsino</surname><given-names>V. N.</given-names></name><name><surname>Frank</surname><given-names>S.</given-names></name><name><surname>Hadzi</surname><given-names>T. C.</given-names></name><name><surname>Myers</surname><given-names>R. H.</given-names></name><name><surname>Latourelle</surname><given-names>J. C.</given-names></name></person-group> (<year>2015b</year>). <article-title>Study of plasma-derived miRNAs mimic differences in Huntington’s disease brain.</article-title>
<source/><italic>Mov. Disord.</italic>
<volume>30</volume>
<fpage>1961</fpage>–<lpage>1964</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26457</pub-id>
<pub-id pub-id-type="pmid">26573701</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>T.</given-names></name><name><surname>Ariizumi</surname><given-names>Y.</given-names></name><name><surname>Shiga</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Tan</surname><given-names>C. F.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>4136</fpage>–<lpage>4147</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt262</pub-id>
<pub-id pub-id-type="pmid">23740936</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname><given-names>C. R.</given-names><suffix>Jr.</suffix></name><name><surname>Albert</surname><given-names>M. S.</given-names></name><name><surname>Knopman</surname><given-names>D. S.</given-names></name><name><surname>McKhann</surname><given-names>G. M.</given-names></name><name><surname>Sperling</surname><given-names>R. A.</given-names></name><name><surname>Carrillo</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>7</volume>
<fpage>257</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.004</pub-id>
<pub-id pub-id-type="pmid">21514247</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>L. H.</given-names></name><name><surname>Liu</surname><given-names>Y. N.</given-names></name></person-group> (<year>2016</year>). <article-title>Downregulated serum miR-223 servers as biomarker in Alzheimer’s disease.</article-title>
<source/><italic>Cell Biochem. Funct.</italic>
<volume>34</volume>
<fpage>233</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.3184</pub-id>
<pub-id pub-id-type="pmid">27027823</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Mu</surname><given-names>J. C.</given-names></name><name><surname>Ackerman</surname><given-names>S. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Mutation of a U2 snRNA gene causes global disruption of alternative splicing and neurodegeneration.</article-title>
<source/><italic>Cell</italic>
<volume>148</volume>
<fpage>296</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.11.057</pub-id>
<pub-id pub-id-type="pmid">22265417</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jutzi</surname><given-names>D.</given-names></name><name><surname>Akinyi</surname><given-names>M. V.</given-names></name><name><surname>Mechtersheimer</surname><given-names>J.</given-names></name><name><surname>Frilander</surname><given-names>M. J.</given-names></name><name><surname>Ruepp</surname><given-names>M.-D.</given-names></name></person-group> (<year>2018</year>). <article-title>The emerging role of minor intron splicing in neurological disorders.</article-title>
<source/><italic>Cell Stress</italic>
<volume>2</volume>
<fpage>40</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.15698/cst2018.03.126</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Weitzer</surname><given-names>S.</given-names></name><name><surname>Pehlivan</surname><given-names>D.</given-names></name><name><surname>Shiraishi</surname><given-names>H.</given-names></name><name><surname>Gogakos</surname><given-names>T.</given-names></name><name><surname>Hanada</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.</article-title>
<source/><italic>Cell</italic>
<volume>157</volume>
<fpage>636</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.02.058</pub-id>
<pub-id pub-id-type="pmid">24766809</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Mieda-Sato</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>3347</fpage>–<lpage>3352</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1112427109</pub-id>
<pub-id pub-id-type="pmid">22323604</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoo</surname><given-names>S. K.</given-names></name><name><surname>Petillo</surname><given-names>D.</given-names></name><name><surname>Kang</surname><given-names>U. J.</given-names></name><name><surname>Resau</surname><given-names>J. H.</given-names></name><name><surname>Berryhill</surname><given-names>B.</given-names></name><name><surname>Linder</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Plasma-based circulating MicroRNA biomarkers for Parkinson’s disease.</article-title>
<source/><italic>J. Parkinsons Dis.</italic>
<volume>2</volume>
<fpage>321</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.3233/jpd-012144</pub-id>
<pub-id pub-id-type="pmid">23938262</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieran</surname><given-names>D.</given-names></name><name><surname>Sebastia</surname><given-names>J.</given-names></name><name><surname>Greenway</surname><given-names>M. J.</given-names></name><name><surname>King</surname><given-names>M. A.</given-names></name><name><surname>Connaughton</surname><given-names>D.</given-names></name><name><surname>Concannon</surname><given-names>C. G.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Control of motoneuron survival by angiogenin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>14056</fpage>–<lpage>14061</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3399-08.2008</pub-id><pub-id pub-id-type="pmid">19109488</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiko</surname><given-names>T.</given-names></name><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Tsuduki</surname><given-names>T.</given-names></name><name><surname>Furukawa</surname><given-names>K.</given-names></name><name><surname>Arai</surname><given-names>H.</given-names></name><name><surname>Miyazawa</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>39</volume>
<fpage>253</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.3233/jad-130932</pub-id>
<pub-id pub-id-type="pmid">24157723</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchner</surname><given-names>S.</given-names></name><name><surname>Ignatova</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging roles of tRNA in adaptive translation, signalling dynamics and disease.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>16</volume>
<fpage>98</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3861</pub-id>
<pub-id pub-id-type="pmid">25534324</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>S.</given-names></name><name><surname>Khanna</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Hui</surname><given-names>J.</given-names></name><name><surname>Balwierz</surname><given-names>P. J.</given-names></name><name><surname>Stefan</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>19</volume>
<fpage>1153</fpage>–<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp585</pub-id>
<pub-id pub-id-type="pmid">20053671</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Dezso</surname><given-names>Z.</given-names></name><name><surname>MacKenzie</surname><given-names>C.</given-names></name><name><surname>Oestreicher</surname><given-names>J.</given-names></name><name><surname>Agoulnik</surname><given-names>S.</given-names></name><name><surname>Byrne</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Circulating miRNA biomarkers for Alzheimer’s disease.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e69807</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0069807</pub-id>
<pub-id pub-id-type="pmid">23922807</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Mudunuri</surname><given-names>S. B.</given-names></name><name><surname>Anaya</surname><given-names>J.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>tRFdb: a database for transfer RNA fragments.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>43</volume>
<fpage>D141</fpage>–<lpage>D145</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1138</pub-id>
<pub-id pub-id-type="pmid">25392422</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Vijayan</surname><given-names>M.</given-names></name><name><surname>Reddy</surname><given-names>P. H.</given-names></name></person-group> (<year>2017</year>). <article-title>MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>3808</fpage>–<lpage>3822</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx267</pub-id>
<pub-id pub-id-type="pmid">28934394</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laufer</surname><given-names>B. I.</given-names></name><name><surname>Mantha</surname><given-names>K.</given-names></name><name><surname>Kleiber</surname><given-names>M. L.</given-names></name><name><surname>Diehl</surname><given-names>E. J.</given-names></name><name><surname>Addison</surname><given-names>S. M.</given-names></name><name><surname>Singh</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice.</article-title>
<source/><italic>Dis. Model. Mech.</italic>
<volume>6</volume>
<fpage>977</fpage>–<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.010975</pub-id>
<pub-id pub-id-type="pmid">23580197</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Thomas</surname><given-names>A.</given-names></name><name><surname>Rogers</surname><given-names>A. K.</given-names></name><name><surname>Webster</surname><given-names>A.</given-names></name><name><surname>Marinov</surname><given-names>G. K.</given-names></name><name><surname>Liao</surname><given-names>S. E.</given-names></name><name><surname>Perkins</surname><given-names>E. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>27</volume>
<fpage>390</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1101/gad.209841.112</pub-id>
<pub-id pub-id-type="pmid">23392610</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. S.</given-names></name><name><surname>Shibata</surname><given-names>Y.</given-names></name><name><surname>Malhotra</surname><given-names>A.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>A novel class of small RNAs: tRNA-derived RNA fragments (tRFs).</article-title>
<source/><italic>Genes Dev.</italic>
<volume>23</volume>
<fpage>2639</fpage>–<lpage>2649</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1837609</pub-id>
<pub-id pub-id-type="pmid">19933153</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>S. M.</given-names></name><name><surname>Kruger</surname><given-names>C.</given-names></name><name><surname>Park</surname><given-names>B.</given-names></name><name><surname>Derkow</surname><given-names>K.</given-names></name><name><surname>Rosenberger</surname><given-names>K.</given-names></name><name><surname>Baumgart</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>15</volume>
<fpage>827</fpage>–<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3113</pub-id>
<pub-id pub-id-type="pmid">22610069</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leidinger</surname><given-names>P.</given-names></name><name><surname>Backes</surname><given-names>C.</given-names></name><name><surname>Deutscher</surname><given-names>S.</given-names></name><name><surname>Schmitt</surname><given-names>K.</given-names></name><name><surname>Mueller</surname><given-names>S. C.</given-names></name><name><surname>Frese</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A blood based 12-miRNA signature of Alzheimer disease patients.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>14</volume>:<issue>R78</issue>. <pub-id pub-id-type="doi">10.1186/gb-2013-14-7-r78</pub-id>
<pub-id pub-id-type="pmid">23895045</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>G. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Emerging role of angiogenin in stress response and cell survival under adverse conditions.</article-title>
<source/><italic>J. Cell. Physiol.</italic>
<volume>227</volume>
<fpage>2822</fpage>–<lpage>2826</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.23051</pub-id>
<pub-id pub-id-type="pmid">22021078</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>J. Y.</given-names></name><name><surname>Ma</surname><given-names>L. M.</given-names></name><name><surname>Guo</surname><given-names>Y. H.</given-names></name><name><surname>Zhang</surname><given-names>Y. C.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Shao</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3’ trailers.</article-title>
<source/><italic>PLoS One</italic>
<volume>5</volume>:<issue>e10563</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010563</pub-id>
<pub-id pub-id-type="pmid">20498841</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>X. Y.</given-names></name><name><surname>Wang</surname><given-names>W. W.</given-names></name><name><surname>Yang</surname><given-names>Z. H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q. S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson’s disease.</article-title>
<source/><italic>Int. J. Genomics</italic>
<volume>2013</volume>:<issue>606919</issue>. <pub-id pub-id-type="doi">10.1155/2013/606919</pub-id>
<pub-id pub-id-type="pmid">24350239</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liguori</surname><given-names>M.</given-names></name><name><surname>Nuzziello</surname><given-names>N.</given-names></name><name><surname>Introna</surname><given-names>A.</given-names></name><name><surname>Consiglio</surname><given-names>A.</given-names></name><name><surname>Licciulli</surname><given-names>F.</given-names></name><name><surname>D’Errico</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>11</volume>:<issue>288</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00288</pub-id>
<pub-id pub-id-type="pmid">30687004</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loche</surname><given-names>E.</given-names></name><name><surname>Ozanne</surname><given-names>S. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Early nutrition, epigenetics, and cardiovascular disease.</article-title>
<source/><italic>Curr. Opin. Lipidol.</italic>
<volume>27</volume>
<fpage>449</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1097/mol.0000000000000338</pub-id>
<pub-id pub-id-type="pmid">27495135</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugli</surname><given-names>G.</given-names></name><name><surname>Cohen</surname><given-names>A. M.</given-names></name><name><surname>Bennett</surname><given-names>D. A.</given-names></name><name><surname>Shah</surname><given-names>R. C.</given-names></name><name><surname>Fields</surname><given-names>C. J.</given-names></name><name><surname>Hernandez</surname><given-names>A. G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0139233</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0139233</pub-id>
<pub-id pub-id-type="pmid">26426747</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus.</article-title>
<source/><italic>Neuroreport</italic>
<volume>18</volume>
<fpage>297</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e3280148e8b</pub-id>
<pub-id pub-id-type="pmid">17314675</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukiw</surname><given-names>W. J.</given-names></name><name><surname>Alexandrov</surname><given-names>P. N.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Bhattacharjee</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Spreading of Alzheimer’s disease inflammatory signaling through soluble micro-RNA.</article-title>
<source/><italic>Neuroreport</italic>
<volume>23</volume>
<fpage>621</fpage>–<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e32835542b0</pub-id>
<pub-id pub-id-type="pmid">22660168</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Serum miR-221 serves as a biomarker for Parkinson’s disease.</article-title>
<source/><italic>Cell Biochem. Funct.</italic>
<volume>34</volume>
<fpage>511</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.3224</pub-id>
<pub-id pub-id-type="pmid">27748571</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>S. R.</given-names></name><name><surname>Juliano</surname><given-names>C. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Untangling the web: the diverse functions of the PIWI/piRNA pathway.</article-title>
<source/><italic>Mol. Reprod. Dev.</italic>
<volume>80</volume>
<fpage>632</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1002/mrd.22195</pub-id>
<pub-id pub-id-type="pmid">23712694</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraia</surname><given-names>R. J.</given-names></name><name><surname>Lamichhane</surname><given-names>T. N.</given-names></name></person-group> (<year>2011</year>). <article-title>3’ processing of eukaryotic precursor tRNAs.</article-title>
<source/><italic>Wiley Interdiscip. Rev. RNA</italic>
<volume>2</volume>
<fpage>362</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1002/wrna.64</pub-id>
<pub-id pub-id-type="pmid">21572561</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margis</surname><given-names>R.</given-names></name><name><surname>Margis</surname><given-names>R.</given-names></name><name><surname>Rieder</surname><given-names>C. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification of blood microRNAs associated to Parkinsonis disease.</article-title>
<source/><italic>J. Biotechnol.</italic>
<volume>152</volume>
<fpage>96</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.01.023</pub-id>
<pub-id pub-id-type="pmid">21295623</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>F. J.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Lee</surname><given-names>J. E.</given-names></name><name><surname>Blanco</surname><given-names>S.</given-names></name><name><surname>Nickerson</surname><given-names>E.</given-names></name><name><surname>Gabriel</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>49</volume>
<fpage>380</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100686</pub-id>
<pub-id pub-id-type="pmid">22577224</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>M.</given-names></name><name><surname>Rosa</surname><given-names>A.</given-names></name><name><surname>Guedes</surname><given-names>L. C.</given-names></name><name><surname>Fonseca</surname><given-names>B. V.</given-names></name><name><surname>Gotovac</surname><given-names>K.</given-names></name><name><surname>Violante</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Convergence of miRNA expression profiling, alpha-synuclein interaction and GWAS in Parkinson’s disease.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e25443</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0025443</pub-id>
<pub-id pub-id-type="pmid">22003392</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massenet</surname><given-names>S.</given-names></name><name><surname>Bertrand</surname><given-names>E.</given-names></name><name><surname>Verheggen</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Assembly and trafficking of box C/D and H/ACA snoRNPs.</article-title>
<source/><italic>RNA Biol.</italic>
<volume>14</volume>
<fpage>680</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2016.1243646</pub-id>
<pub-id pub-id-type="pmid">27715451</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matamala</surname><given-names>J. M.</given-names></name><name><surname>Arias-Carrasco</surname><given-names>R.</given-names></name><name><surname>Sanchez</surname><given-names>C.</given-names></name><name><surname>Uhrig</surname><given-names>M.</given-names></name><name><surname>Bargsted</surname><given-names>L.</given-names></name><name><surname>Matus</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>64</volume>
<fpage>123</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.12.020</pub-id>
<pub-id pub-id-type="pmid">29458840</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matera</surname><given-names>A. G.</given-names></name><name><surname>Terns</surname><given-names>R. M.</given-names></name><name><surname>Terns</surname><given-names>M. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>8</volume>
<fpage>209</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2124</pub-id>
<pub-id pub-id-type="pmid">17318225</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname><given-names>G. M.</given-names></name><name><surname>Knopman</surname><given-names>D. S.</given-names></name><name><surname>Chertkow</surname><given-names>H.</given-names></name><name><surname>Hyman</surname><given-names>B. T.</given-names></name><name><surname>Jack</surname><given-names>C. R.</given-names><suffix>Jr.</suffix></name><name><surname>Kawas</surname><given-names>C. H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>7</volume>
<fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.005</pub-id>
<pub-id pub-id-type="pmid">21514250</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minones-Moyano</surname><given-names>E.</given-names></name><name><surname>Porta</surname><given-names>S.</given-names></name><name><surname>Escaramis</surname><given-names>G.</given-names></name><name><surname>Rabionet</surname><given-names>R.</given-names></name><name><surname>Iraola</surname><given-names>S.</given-names></name><name><surname>Kagerbauer</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>MicroRNA profiling of Parkinson’s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>3067</fpage>–<lpage>3078</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr210</pub-id>
<pub-id pub-id-type="pmid">21558425</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Culla</surname><given-names>M.</given-names></name><name><surname>Irizar</surname><given-names>H.</given-names></name><name><surname>Saenz-Cuesta</surname><given-names>M.</given-names></name><name><surname>Castillo-Trivino</surname><given-names>T.</given-names></name><name><surname>Osorio-Querejeta</surname><given-names>I.</given-names></name><name><surname>Sepulveda</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>SncRNA (microRNA &amp;snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>20126</issue>. <pub-id pub-id-type="doi">10.1038/srep20126</pub-id>
<pub-id pub-id-type="pmid">26831009</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaraj</surname><given-names>S.</given-names></name><name><surname>Laskowska-Kaszub</surname><given-names>K.</given-names></name><name><surname>Debski</surname><given-names>K. J.</given-names></name><name><surname>Wojsiat</surname><given-names>J.</given-names></name><name><surname>Dabrowski</surname><given-names>M.</given-names></name><name><surname>Gabryelewicz</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects.</article-title>
<source/><italic>Oncotarget</italic>
<volume>8</volume>
<fpage>16122</fpage>–<lpage>16143</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.15109</pub-id>
<pub-id pub-id-type="pmid">28179587</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagatsua</surname><given-names>T.</given-names></name><name><surname>Sawadab</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>L-dopa therapy for Parkinson’s disease: past, present, and future.</article-title>
<source/><italic>Parkinsonism Relat. Disord.</italic>
<volume>15</volume>(Suppl. 1), <fpage>S3</fpage>–<lpage>S8</lpage>. <pub-id pub-id-type="doi">10.1016/s1353-8020(09)70004-5</pub-id><pub-id pub-id-type="pmid">19131039</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>J.</given-names></name><name><surname>Hayder</surname><given-names>H.</given-names></name><name><surname>Zayed</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Overview of MicroRNA biogenesis, mechanisms of actions, and circulation.</article-title>
<source/><italic>Front. Endocrinol.</italic>
<volume>9</volume>:<issue>402</issue>. <pub-id pub-id-type="doi">10.3389/fendo.2018.00402</pub-id>
<pub-id pub-id-type="pmid">30123182</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtani</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Transcriptional regulation of snRNAs and its significance for plant development.</article-title>
<source/><italic>J. Plant Res.</italic>
<volume>130</volume>
<fpage>57</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/s10265-016-0883-3</pub-id>
<pub-id pub-id-type="pmid">27900551</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>A. N.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Harper</surname><given-names>S. Q.</given-names></name><name><surname>Jones</surname><given-names>L.</given-names></name><name><surname>Davidson</surname><given-names>B. L.</given-names></name></person-group> (<year>2008</year>). <article-title>The bifunctional microRNA miR-9/miR-9<sup>∗</sup> regulates REST and CoREST and is downregulated in Huntington’s disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>14341</fpage>–<lpage>14346</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2390-08.2008</pub-id><pub-id pub-id-type="pmid">19118166</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palazzo</surname><given-names>A. F.</given-names></name><name><surname>Lee</surname><given-names>E. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Non-coding RNA: what is functional and what is junk?</article-title>
<source/><italic>Front. Genet.</italic>
<volume>6</volume>:<issue>2</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2015.00002</pub-id>
<pub-id pub-id-type="pmid">25674102</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rachakonda</surname><given-names>V.</given-names></name><name><surname>Pan</surname><given-names>T. H.</given-names></name><name><surname>Le</surname><given-names>W. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Biomarkers of neurodegenerative disorders: how good are they?</article-title>
<source/><italic>Cell Res.</italic>
<volume>14</volume>
<fpage>347</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cr.7290235</pub-id>
<pub-id pub-id-type="pmid">15538967</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raheja</surname><given-names>R.</given-names></name><name><surname>Regev</surname><given-names>K.</given-names></name><name><surname>Healy</surname><given-names>B. C.</given-names></name><name><surname>Mazzola</surname><given-names>M. A.</given-names></name><name><surname>Beynon</surname><given-names>V.</given-names></name><name><surname>Von Glehn</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Correlating serum microRNAs and clinical parameters in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Muscle Nerve</italic>
<volume>58</volume>
<fpage>261</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1002/mus.26106</pub-id>
<pub-id pub-id-type="pmid">29466830</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratti</surname><given-names>A.</given-names></name><name><surname>Buratti</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>138</volume>(Suppl. 1), <fpage>95</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13625</pub-id>
<pub-id pub-id-type="pmid">27015757</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>S.</given-names></name><name><surname>Stettler</surname><given-names>J.</given-names></name><name><surname>Filosa</surname><given-names>G.</given-names></name><name><surname>Colombo</surname><given-names>M.</given-names></name><name><surname>Jutzi</surname><given-names>D.</given-names></name><name><surname>Lenzken</surname><given-names>S. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.</article-title>
<source/><italic>EMBO J.</italic>
<volume>35</volume>
<fpage>1504</fpage>–<lpage>1521</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201593791</pub-id>
<pub-id pub-id-type="pmid">27252488</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>E. R.</given-names></name><name><surname>Latourelle</surname><given-names>J. C.</given-names></name><name><surname>Bockholt</surname><given-names>J. H.</given-names></name><name><surname>Bregu</surname><given-names>J.</given-names></name><name><surname>Smock</surname><given-names>J.</given-names></name><name><surname>Paulsen</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.</article-title>
<source/><italic>Neurology</italic>
<volume>90</volume>
<fpage>e264</fpage>–<lpage>e272</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000004844</pub-id>
<pub-id pub-id-type="pmid">29282329</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>C.</given-names></name><name><surname>Marzocchi</surname><given-names>C.</given-names></name><name><surname>Battistini</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>MicroRNAs as biomarkers in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Cells</italic>
<volume>7</volume>:<issue>E219</issue>. <pub-id pub-id-type="doi">10.3390/cells7110219</pub-id>
<pub-id pub-id-type="pmid">30463376</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>F.</given-names></name><name><surname>Rinaldi</surname><given-names>A.</given-names></name><name><surname>Marchese</surname><given-names>G.</given-names></name><name><surname>Coviello</surname><given-names>E.</given-names></name><name><surname>Sellitto</surname><given-names>A.</given-names></name><name><surname>Cordella</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.</article-title>
<source/><italic>Oncotarget</italic>
<volume>7</volume>
<fpage>54650</fpage>–<lpage>54661</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.10567</pub-id>
<pub-id pub-id-type="pmid">27429044</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>J.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Parida</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>Z.</given-names></name><name><surname>Mallick</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Small RNA sequencing revealed dysregulated piRNAs in Alzheimer’s disease and their probable role in pathogenesis.</article-title>
<source/><italic>Mol. Biosyst.</italic>
<volume>13</volume>
<fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1039/c6mb00699j</pub-id>
<pub-id pub-id-type="pmid">28127595</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala Frigerio</surname><given-names>C.</given-names></name><name><surname>Lau</surname><given-names>P.</given-names></name><name><surname>Salta</surname><given-names>E.</given-names></name><name><surname>Tournoy</surname><given-names>J.</given-names></name><name><surname>Bossers</surname><given-names>K.</given-names></name><name><surname>Vandenberghe</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease.</article-title>
<source/><italic>Neurology</italic>
<volume>81</volume>
<fpage>2103</fpage>–<lpage>2106</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000437306.37850.22</pub-id>
<pub-id pub-id-type="pmid">24212398</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>A. E.</given-names></name><name><surname>Eggens</surname><given-names>V. R.</given-names></name><name><surname>Caglayan</surname><given-names>A. O.</given-names></name><name><surname>Reuter</surname><given-names>M. S.</given-names></name><name><surname>Scott</surname><given-names>E.</given-names></name><name><surname>Coufal</surname><given-names>N. G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration.</article-title>
<source/><italic>Cell</italic>
<volume>157</volume>
<fpage>651</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.049</pub-id>
<pub-id pub-id-type="pmid">24766810</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schipper</surname><given-names>H. M.</given-names></name><name><surname>Maes</surname><given-names>O. C.</given-names></name><name><surname>Chertkow</surname><given-names>H. M.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>MicroRNA expression in Alzheimer blood mononuclear cells.</article-title>
<source/><italic>Gene Regul. Syst. Bio.</italic>
<volume>1</volume>
<fpage>263</fpage>–<lpage>274</lpage>.</mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>M.</given-names></name><name><surname>Sommer</surname><given-names>A.</given-names></name><name><surname>Plotz</surname><given-names>S.</given-names></name><name><surname>Farrell</surname><given-names>M.</given-names></name><name><surname>Winner</surname><given-names>B.</given-names></name><name><surname>Grosch</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Sporadic Parkinson’s disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>6</volume>:<issue>58</issue>. <pub-id pub-id-type="doi">10.1186/s40478-018-0561-x</pub-id>
<pub-id pub-id-type="pmid">29986767</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serafin</surname><given-names>A.</given-names></name><name><surname>Foco</surname><given-names>L.</given-names></name><name><surname>Blankenburg</surname><given-names>H.</given-names></name><name><surname>Picard</surname><given-names>A.</given-names></name><name><surname>Zanigni</surname><given-names>S.</given-names></name><name><surname>Zanon</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson’s disease blood samples.</article-title>
<source/><italic>BMC Res. Notes</italic>
<volume>7</volume>:<issue>715</issue>. <pub-id pub-id-type="doi">10.1186/1756-0500-7-715</pub-id>
<pub-id pub-id-type="pmid">25304816</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serafin</surname><given-names>A.</given-names></name><name><surname>Foco</surname><given-names>L.</given-names></name><name><surname>Zanigni</surname><given-names>S.</given-names></name><name><surname>Blankenburg</surname><given-names>H.</given-names></name><name><surname>Picard</surname><given-names>A.</given-names></name><name><surname>Zanon</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD.</article-title>
<source/><italic>Neurology</italic>
<volume>84</volume>
<fpage>645</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000001258</pub-id>
<pub-id pub-id-type="pmid">25596505</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>E.</given-names></name><name><surname>Sterne-Weiler</surname><given-names>T. O.</given-names></name><name><surname>Hanlon</surname><given-names>D.</given-names></name><name><surname>Blencowe</surname><given-names>B. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Global mapping of human RNA-RNA interactions.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>62</volume>
<fpage>618</fpage>–<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2016.04.030</pub-id>
<pub-id pub-id-type="pmid">27184080</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheinerman</surname><given-names>K. S.</given-names></name><name><surname>Toledo</surname><given-names>J. B.</given-names></name><name><surname>Tsivinsky</surname><given-names>V. G.</given-names></name><name><surname>Irwin</surname><given-names>D.</given-names></name><name><surname>Grossman</surname><given-names>M.</given-names></name><name><surname>Weintraub</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.</article-title>
<source/><italic>Alzheimers Res. Ther.</italic>
<volume>9</volume>:<issue>89</issue>. <pub-id pub-id-type="doi">10.1186/s13195-017-0316-0</pub-id>
<pub-id pub-id-type="pmid">29121998</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheinerman</surname><given-names>K. S.</given-names></name><name><surname>Umansky</surname><given-names>S. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Early detection of neurodegenerative diseases: circulating brain-enriched microRNA.</article-title>
<source/><italic>Cell Cycle</italic>
<volume>12</volume>
<fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.4161/cc.23067</pub-id>
<pub-id pub-id-type="pmid">23255116</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shioya</surname><given-names>M.</given-names></name><name><surname>Obayashi</surname><given-names>S.</given-names></name><name><surname>Tabunoki</surname><given-names>H.</given-names></name><name><surname>Arima</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Ishida</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.</article-title>
<source/><italic>Neuropathol. Appl. Neurobiol.</italic>
<volume>36</volume>
<fpage>320</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2010.01076.x</pub-id>
<pub-id pub-id-type="pmid">20202123</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>S. S.</given-names></name><name><surname>Nygaard</surname><given-names>A. B.</given-names></name><name><surname>Christensen</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study.</article-title>
<source/><italic>Transl. Neurodegener.</italic>
<volume>5</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/s40035-016-0053-5</pub-id>
<pub-id pub-id-type="pmid">26981236</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soreq</surname><given-names>L.</given-names></name><name><surname>Salomonis</surname><given-names>N.</given-names></name><name><surname>Bronstein</surname><given-names>M.</given-names></name><name><surname>Greenberg</surname><given-names>D. S.</given-names></name><name><surname>Israel</surname><given-names>Z.</given-names></name><name><surname>Bergman</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>6</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2013.00010</pub-id>
<pub-id pub-id-type="pmid">23717260</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spano</surname><given-names>M.</given-names></name><name><surname>Signorelli</surname><given-names>M.</given-names></name><name><surname>Vitaliani</surname><given-names>R.</given-names></name><name><surname>Aguglia</surname><given-names>E.</given-names></name><name><surname>Giometto</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review.</article-title>
<source/><italic>Funct. Neurol.</italic>
<volume>30</volume>
<fpage>151</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="pmid">26346695</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamova</surname><given-names>B.</given-names></name><name><surname>Ander</surname><given-names>B. P.</given-names></name><name><surname>Barger</surname><given-names>N.</given-names></name><name><surname>Sharp</surname><given-names>F. R.</given-names></name><name><surname>Schumann</surname><given-names>C. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Specific regional and age-related small noncoding RNA expression patterns within superior temporal gyrus of typical human brains are less distinct in autism brains.</article-title>
<source/><italic>J. Child Neurol.</italic>
<volume>30</volume>
<fpage>1930</fpage>–<lpage>1946</lpage>. <pub-id pub-id-type="doi">10.1177/0883073815602067</pub-id>
<pub-id pub-id-type="pmid">26350727</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>tRNA-derived fragments as novel predictive biomarkers for trastuzumab-resistant breast cancer.</article-title>
<source/><italic>Cell. Physiol. Biochem.</italic>
<volume>49</volume>
<fpage>419</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1159/000492977</pub-id>
<pub-id pub-id-type="pmid">30153663</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swarbrick</surname><given-names>S.</given-names></name><name><surname>Wragg</surname><given-names>N.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Stolzing</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Systematic review of miRNA as biomarkers in Alzheimer’s disease.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<pub-id pub-id-type="doi">10.1007/s12035-019-1500-y</pub-id>
<pub-id pub-id-type="pmid">30734227</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>I.</given-names></name><name><surname>Hama</surname><given-names>Y.</given-names></name><name><surname>Matsushima</surname><given-names>M.</given-names></name><name><surname>Hirotani</surname><given-names>M.</given-names></name><name><surname>Kano</surname><given-names>T.</given-names></name><name><surname>Hohzen</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.</article-title>
<source/><italic>Mol. Brain</italic>
<volume>8</volume>:<issue>67</issue>. <pub-id pub-id-type="doi">10.1186/s13041-015-0161-7</pub-id>
<pub-id pub-id-type="pmid">26497046</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>J. T.</given-names></name><name><surname>Liu</surname><given-names>Q. Y.</given-names></name><name><surname>Tan</surname><given-names>M. S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014a</year>). <article-title>Circulating miR-125b as a biomarker of Alzheimer’s disease.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>336</volume>
<fpage>52</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2013.10.002</pub-id>
<pub-id pub-id-type="pmid">24139697</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>J. T.</given-names></name><name><surname>Tan</surname><given-names>M. S.</given-names></name><name><surname>Liu</surname><given-names>Q. Y.</given-names></name><name><surname>Wang</surname><given-names>H. F.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2014b</year>). <article-title>Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>40</volume>
<fpage>1017</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.3233/jad-132144</pub-id>
<pub-id pub-id-type="pmid">24577456</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasca</surname><given-names>E.</given-names></name><name><surname>Pegoraro</surname><given-names>V.</given-names></name><name><surname>Merico</surname><given-names>A.</given-names></name><name><surname>Angelini</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS.</article-title>
<source/><italic>Clin. Neuropathol.</italic>
<volume>35</volume>
<fpage>22</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.5414/np300889</pub-id>
<pub-id pub-id-type="pmid">26588026</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatura</surname><given-names>R.</given-names></name><name><surname>Kraus</surname><given-names>T.</given-names></name><name><surname>Giese</surname><given-names>A.</given-names></name><name><surname>Arzberger</surname><given-names>T.</given-names></name><name><surname>Buchholz</surname><given-names>M.</given-names></name><name><surname>Hoglinger</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Parkinson’s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.</article-title>
<source/><italic>Parkinsonism Relat. Disord.</italic>
<volume>33</volume>
<fpage>115</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2016.09.028</pub-id>
<pub-id pub-id-type="pmid">27717584</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toivonen</surname><given-names>J. M.</given-names></name><name><surname>Manzano</surname><given-names>R.</given-names></name><name><surname>Olivan</surname><given-names>S.</given-names></name><name><surname>Zaragoza</surname><given-names>P.</given-names></name><name><surname>Garcia-Redondo</surname><given-names>A.</given-names></name><name><surname>Osta</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e89065</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0089065</pub-id>
<pub-id pub-id-type="pmid">24586506</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tollervey</surname><given-names>D.</given-names></name><name><surname>Hurt</surname><given-names>E. C.</given-names></name></person-group> (<year>1990</year>). <article-title>The role of small nucleolar ribonucleoproteins in ribosome synthesis.</article-title>
<source/><italic>Mol. Biol. Rep.</italic>
<volume>14</volume>
<fpage>103</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">2141891</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>K. F.</given-names></name><name><surname>Pezic</surname><given-names>D.</given-names></name><name><surname>Stuwe</surname><given-names>E.</given-names></name><name><surname>Webster</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>The piRNA pathway guards the germline genome against transposable elements.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>886</volume>
<fpage>51</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-017-7417-8_4</pub-id>
<pub-id pub-id-type="pmid">26659487</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuiji</surname><given-names>H.</given-names></name><name><surname>Iguchi</surname><given-names>Y.</given-names></name><name><surname>Furuya</surname><given-names>A.</given-names></name><name><surname>Kataoka</surname><given-names>A.</given-names></name><name><surname>Hatsuta</surname><given-names>H.</given-names></name><name><surname>Atsuta</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>5</volume>
<fpage>221</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201202303</pub-id>
<pub-id pub-id-type="pmid">23255347</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tycowski</surname><given-names>K. T.</given-names></name><name><surname>You</surname><given-names>Z. H.</given-names></name><name><surname>Graham</surname><given-names>P. J.</given-names></name><name><surname>Steitz</surname><given-names>J. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Modification of U6 spliceosomal RNA is guided by other small RNAs.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>2</volume>
<fpage>629</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">9844635</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagnozzi</surname><given-names>R.</given-names></name><name><surname>Signoretti</surname><given-names>S.</given-names></name><name><surname>Tavazzi</surname><given-names>B.</given-names></name><name><surname>Floris</surname><given-names>R.</given-names></name><name><surname>Ludovici</surname><given-names>A.</given-names></name><name><surname>Marziali</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes–part III.</article-title>
<source/><italic>Neurosurgery</italic>
<volume>62</volume>
<fpage>1286</fpage>–<lpage>1295</lpage>; discussion <fpage>1295</fpage>–<lpage>1296</lpage>. <pub-id pub-id-type="doi">10.1227/01.neu.0000333300.34189.74</pub-id>
<pub-id pub-id-type="pmid">18824995</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallelunga</surname><given-names>A.</given-names></name><name><surname>Ragusa</surname><given-names>M.</given-names></name><name><surname>Di Mauro</surname><given-names>S.</given-names></name><name><surname>Iannitti</surname><given-names>T.</given-names></name><name><surname>Pilleri</surname><given-names>M.</given-names></name><name><surname>Biundo</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of circulating microRNAs for the differential diagnosis of Parkinson’s disease and Multiple System Atrophy.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>156</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00156</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Es</surname><given-names>M. A.</given-names></name><name><surname>Schelhaas</surname><given-names>H. J.</given-names></name><name><surname>van Vught</surname><given-names>P. W.</given-names></name><name><surname>Ticozzi</surname><given-names>N.</given-names></name><name><surname>Andersen</surname><given-names>P. M.</given-names></name><name><surname>Groen</surname><given-names>E. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>70</volume>
<fpage>964</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22611</pub-id>
<pub-id pub-id-type="pmid">22190368</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazquez-Arango</surname><given-names>P.</given-names></name><name><surname>Vowles</surname><given-names>J.</given-names></name><name><surname>Browne</surname><given-names>C.</given-names></name><name><surname>Hartfield</surname><given-names>E.</given-names></name><name><surname>Fernandes</surname><given-names>H. J.</given-names></name><name><surname>Mandefro</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>44</volume>
<fpage>10960</fpage>–<lpage>10973</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw711</pub-id>
<pub-id pub-id-type="pmid">27536002</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>B.</given-names></name><name><surname>Akinyi</surname><given-names>M. V.</given-names></name><name><surname>Norppa</surname><given-names>A. J.</given-names></name><name><surname>Frilander</surname><given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Minor spliceosome and disease.</article-title>
<source/><italic>Semin. Cell Dev. Biol.</italic>
<volume>79</volume>
<fpage>103</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2017.09.036</pub-id>
<pub-id pub-id-type="pmid">28965864</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>C.</given-names></name><name><surname>Ridolfi</surname><given-names>E.</given-names></name><name><surname>Fenoglio</surname><given-names>C.</given-names></name><name><surname>Ghezzi</surname><given-names>L.</given-names></name><name><surname>Vimercati</surname><given-names>R.</given-names></name><name><surname>Clerici</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>35</volume>
<fpage>487</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.3233/jad-122263</pub-id>
<pub-id pub-id-type="pmid">23435408</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Johnston</surname><given-names>P.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology.</article-title>
<source/><italic>Nature</italic>
<volume>474</volume>
<fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl</surname><given-names>M. C.</given-names></name><name><surname>Will</surname><given-names>C. L.</given-names></name><name><surname>Luhrmann</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>The spliceosome: design principles of a dynamic RNP machine.</article-title>
<source/><italic>Cell</italic>
<volume>136</volume>
<fpage>701</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.02.009</pub-id>
<pub-id pub-id-type="pmid">19239890</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>C.</given-names></name><name><surname>Labadorf</surname><given-names>A.</given-names></name><name><surname>Dumitriu</surname><given-names>A.</given-names></name><name><surname>Hoss</surname><given-names>A. G.</given-names></name><name><surname>Bregu</surname><given-names>J.</given-names></name><name><surname>Albrecht</surname><given-names>K. H.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Novel microRNA discovery using small RNA sequencing in post-mortem human brain.</article-title>
<source/><italic>BMC Genomics</italic>
<volume>17</volume>:<issue>776</issue>. <pub-id pub-id-type="doi">10.1186/s12864-016-3114-3</pub-id>
<pub-id pub-id-type="pmid">27716130</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>R.</given-names></name><name><surname>Goodall</surname><given-names>E. F.</given-names></name><name><surname>Milo</surname><given-names>M.</given-names></name><name><surname>Cooper-Knock</surname><given-names>J.</given-names></name><name><surname>Da Costa</surname><given-names>M.</given-names></name><name><surname>Hobson</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017a</year>). <article-title>Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>55</volume>
<fpage>123</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.03.027</pub-id>
<pub-id pub-id-type="pmid">28454844</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>R.</given-names></name><name><surname>Wyles</surname><given-names>M.</given-names></name><name><surname>Heath</surname><given-names>P. R.</given-names></name><name><surname>Kazoka</surname><given-names>M.</given-names></name><name><surname>Wollff</surname><given-names>H.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2017b</year>). <article-title>Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>731</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00731</pub-id>
<pub-id pub-id-type="pmid">29375285</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W. X.</given-names></name><name><surname>Rajeev</surname><given-names>B. W.</given-names></name><name><surname>Stromberg</surname><given-names>A. J.</given-names></name><name><surname>Ren</surname><given-names>N.</given-names></name><name><surname>Tang</surname><given-names>G.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>1213</fpage>–<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5065-07.2008</pub-id>
<pub-id pub-id-type="pmid">18234899</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>J. H.</given-names></name><name><surname>Rajpurohit</surname><given-names>A.</given-names></name><name><surname>Deep-Soboslay</surname><given-names>A.</given-names></name><name><surname>Collado-Torres</surname><given-names>L.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Altered expression of histamine signaling genes in autism spectrum disorder.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>7</volume>:<issue>e1126</issue>. <pub-id pub-id-type="doi">10.1038/tp.2017.87</pub-id>
<pub-id pub-id-type="pmid">28485729</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Jiao</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Lower serum levels of miR-29c-3p and miR-19b-3p as biomarkers for Alzheimer’s disease.</article-title>
<source/><italic>Tohoku J. Exp. Med.</italic>
<volume>242</volume>
<fpage>129</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1620/tjem.242.129</pub-id>
<pub-id pub-id-type="pmid">28626163</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>S.</given-names></name><name><surname>Ivanov</surname><given-names>P.</given-names></name><name><surname>Hu</surname><given-names>G. F.</given-names></name><name><surname>Anderson</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Angiogenin cleaves tRNA and promotes stress-induced translational repression.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>185</volume>
<fpage>35</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200811106</pub-id>
<pub-id pub-id-type="pmid">19332886</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>H. Y.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Maierhofer</surname><given-names>V.</given-names></name><name><surname>Neb</surname><given-names>E.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Widespread expression of piRNA-like molecules in somatic tissues.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>39</volume>
<fpage>6596</fpage>–<lpage>6607</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr298</pub-id>
<pub-id pub-id-type="pmid">21546553</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Gu</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Detection of stably expressed piRNAs in human blood.</article-title>
<source/><italic>Int. J. Clin. Exp. Med.</italic>
<volume>8</volume>
<fpage>13353</fpage>–<lpage>13358</lpage>. <pub-id pub-id-type="pmid">26550265</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>S. G.</given-names></name><name><surname>Erdal</surname><given-names>M. E.</given-names></name><name><surname>Ozge</surname><given-names>A. A.</given-names></name><name><surname>Sungur</surname><given-names>M. A.</given-names></name></person-group> (<year>2016a</year>). <article-title>Can peripheral MicroRNA expression data serve as epigenomic (Upstream) biomarkers of Alzheimer’s disease?</article-title>
<source/><italic>OMICS</italic>
<volume>20</volume>
<fpage>456</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2016.0099</pub-id>
<pub-id pub-id-type="pmid">27501295</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>S. G.</given-names></name><name><surname>Geyik</surname><given-names>S.</given-names></name><name><surname>Neyal</surname><given-names>A. M.</given-names></name><name><surname>Soko</surname><given-names>N. D.</given-names></name><name><surname>Bozkurt</surname><given-names>H.</given-names></name><name><surname>Dandara</surname><given-names>C.</given-names></name></person-group> (<year>2016b</year>). <article-title>Hypothesis: do miRNAs targeting the leucine-rich repeat kinase 2 gene (LRRK2) influence Parkinson’s disease susceptibility?</article-title>
<source/><italic>OMICS</italic>
<volume>20</volume>
<fpage>224</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2016.0040</pub-id>
<pub-id pub-id-type="pmid">27093107</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>S.</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R.</given-names></name><name><surname>Kunz</surname><given-names>R. C.</given-names></name><name><surname>Gangopadhyay</surname><given-names>J.</given-names></name><name><surname>Borufka</surname><given-names>C.</given-names></name><name><surname>Gygi</surname><given-names>S. P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause Mis-splicing in ALS/FTD Patients.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>19</volume>
<fpage>2244</fpage>–<lpage>2256</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.056</pub-id>
<pub-id pub-id-type="pmid">28614712</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Qian</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Nie</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Expression of microRNA222 in serum of patients with Alzheimer’s disease.</article-title>
<source/><italic>Mol. Med. Rep.</italic>
<volume>16</volume>
<fpage>5575</fpage>–<lpage>5579</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2017.7301</pub-id>
<pub-id pub-id-type="pmid">28849039</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Y. C.</given-names></name><name><surname>Mullane</surname><given-names>P.</given-names></name><name><surname>Ji</surname><given-names>Y. J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>FUS regulates activity of MicroRNA-mediated gene silencing.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>69</volume>
<fpage>787</fpage>–<lpage>801</lpage>.e8. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.001</pub-id>
<pub-id pub-id-type="pmid">29499134</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Lotti</surname><given-names>F.</given-names></name><name><surname>Dittmar</surname><given-names>K.</given-names></name><name><surname>Younis</surname><given-names>I.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Kasim</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.</article-title>
<source/><italic>Cell</italic>
<volume>133</volume>
<fpage>585</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.03.031</pub-id>
<pub-id pub-id-type="pmid">18485868</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Pinto</surname><given-names>A. M.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Berg</surname><given-names>M. G.</given-names></name><name><surname>Oliva</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>19348</fpage>–<lpage>19353</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1319280110</pub-id>
<pub-id pub-id-type="pmid">24191055</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Yue</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The role of MicroRNAs in Abeta deposition and tau phosphorylation in Alzheimer’s disease.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>8</volume>:<issue>342</issue>
<pub-id pub-id-type="doi">10.3389/fneur.2017.00342</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Fei</surname><given-names>G.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson’s disease.</article-title>
<source/><italic>Parkinsonism Relat. Disord.</italic>
<volume>20</volume>
<fpage>1177</fpage>–<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2014.08.016</pub-id>
<pub-id pub-id-type="pmid">25218846</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>